FR2689017B1
(fr)
*
|
1992-03-31 |
1994-05-27 |
Mtc Medical |
Appareil d'injection medicale ou veterinaire.
|
US5383851A
(en)
*
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5405333A
(en)
*
|
1992-12-28 |
1995-04-11 |
Richmond; Frank M. |
Liquid medicament bag with needleless connector fitting using boat assembly
|
US6206860B1
(en)
|
1993-07-28 |
2001-03-27 |
Frank M. Richmond |
Spikeless connection and drip chamber with valve
|
US5540657A
(en)
*
|
1994-07-15 |
1996-07-30 |
Collagen Corporation |
Delivery device for injectable materials
|
DE19519279A1
(de)
*
|
1994-12-07 |
1996-08-22 |
Wolfgang Dr Med Wagner |
Verfahren und Einrichtung zur Saug-Druckinjektion
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
DE29507987U1
(de)
*
|
1995-05-15 |
1996-09-19 |
Ferton Holding |
Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
|
US5893397A
(en)
*
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
US5800388A
(en)
|
1996-02-29 |
1998-09-01 |
Medi-Ject Corporation |
Plunger/ram assembly adapted for a fluid injector
|
US5697917A
(en)
|
1996-02-29 |
1997-12-16 |
Medi-Ject Corporation |
Nozzle assembly with adjustable plunger travel gap
|
US5722953A
(en)
|
1996-02-29 |
1998-03-03 |
Medi-Ject Corporation |
Nozzle assembly for injection device
|
US5643211A
(en)
|
1996-02-29 |
1997-07-01 |
Medi-Ject Corporation |
Nozzle assembly having a frangible plunger
|
US5921967A
(en)
|
1996-02-29 |
1999-07-13 |
Medi-Ject Corporation |
Plunger for nozzle assembly
|
US5865795A
(en)
|
1996-02-29 |
1999-02-02 |
Medi-Ject Corporation |
Safety mechanism for injection devices
|
US5785688A
(en)
*
|
1996-05-07 |
1998-07-28 |
Ceramatec, Inc. |
Fluid delivery apparatus and method
|
KR100376646B1
(ko)
|
1996-07-01 |
2003-03-15 |
파마시아 에이비 |
전달 장치 및 이것의 작동 방법
|
US6458574B1
(en)
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
US6106502A
(en)
*
|
1996-12-18 |
2000-08-22 |
Richmond; Frank M. |
IV sets with needleless fittings and valves
|
US5875976A
(en)
|
1996-12-24 |
1999-03-02 |
Medi-Ject Corporation |
Locking mechanism for nozzle assembly
|
US5993412A
(en)
*
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
US5911703A
(en)
*
|
1997-05-22 |
1999-06-15 |
Avant Drug Delivery Systems, Inc. |
Two-stage fluid medicament jet injector
|
US5947928A
(en)
*
|
1997-06-19 |
1999-09-07 |
Mile Creek Capital, Llc |
Drug delivery system
|
US5964735A
(en)
*
|
1997-07-01 |
1999-10-12 |
Medisys Technologies, Inc. |
Fine needle aspiration safety syringe
|
EP0888790A1
(de)
*
|
1997-07-04 |
1999-01-07 |
PowderJect Research Limited |
Vorrichtung zur Abgabe von Medikamententeilchen
|
US6569127B1
(en)
*
|
1997-07-18 |
2003-05-27 |
Liebel-Flarsheim Company |
Adapter and syringe for front-loading medical fluid injector
|
US6171276B1
(en)
|
1997-08-06 |
2001-01-09 |
Pharmacia & Upjohn Ab |
Automated delivery device and method for its operation
|
US6071272A
(en)
*
|
1997-10-28 |
2000-06-06 |
Hoffman; Alan S. |
Method for treating erectile dysfunctionality
|
US6610042B2
(en)
|
1997-12-05 |
2003-08-26 |
Felton Medical, Inc. |
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
|
US6541606B2
(en)
*
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
US5993418A
(en)
*
|
1998-02-24 |
1999-11-30 |
Medisys Technologies, Inc. |
Safety syringe
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
EP1071377A1
(de)
|
1998-04-14 |
2001-01-31 |
Merck & Co., Inc. |
Nadellose verabreichung von polynukleotiden formationen
|
ATE342079T1
(de)
*
|
1998-07-27 |
2006-11-15 |
Antares Pharma Inc |
Injektionshilfstorpedo für ein medizinisches injektionssystem
|
CN1320050A
(zh)
*
|
1998-07-27 |
2001-10-31 |
梅迪-杰克特公司 |
用于药物注射器装置的充药机构
|
GB9818110D0
(en)
*
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
EP1109594B1
(de)
|
1998-08-31 |
2004-10-27 |
Johnson & Johnson Consumer Companies, Inc. |
Elektrotransportvorrichtung mit klingen
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US6783509B1
(en)
|
1998-11-18 |
2004-08-31 |
Bioject Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6383168B1
(en)
|
1998-12-08 |
2002-05-07 |
Bioject Medical Technologies Inc. |
Needleless syringe with prefilled cartridge
|
US6132395A
(en)
*
|
1998-12-08 |
2000-10-17 |
Bioject, Inc. |
Needleless syringe with prefilled cartridge
|
US6406455B1
(en)
*
|
1998-12-18 |
2002-06-18 |
Biovalve Technologies, Inc. |
Injection devices
|
DE19859137C1
(de)
*
|
1998-12-21 |
2000-05-18 |
Ferton Holding Sa |
Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
|
US6328714B1
(en)
|
1999-01-29 |
2001-12-11 |
Powderject Research Limited |
Particle delivery device
|
US6849060B1
(en)
|
1999-01-29 |
2005-02-01 |
Powderject Research Limited |
Particle delivery device
|
WO2000062857A1
(en)
|
1999-04-16 |
2000-10-26 |
Johnson & Johnson Consumer Companies, Inc. |
Electrotransport delivery system comprising internal sensors
|
US7060048B1
(en)
*
|
1999-04-16 |
2006-06-13 |
Powerject Research Limited |
Needleless syringe
|
US6689095B1
(en)
|
1999-04-22 |
2004-02-10 |
Gilbert Garitano |
Needleless permanent makeup and tattoo device
|
US6319230B1
(en)
|
1999-05-07 |
2001-11-20 |
Scimed Life Systems, Inc. |
Lateral needle injection apparatus and method
|
US6689103B1
(en)
|
1999-05-07 |
2004-02-10 |
Scimed Life System, Inc. |
Injection array apparatus and method
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
WO2000072908A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Microheart, Inc. |
Devices and methods for delivering a drug
|
AU6076200A
(en)
|
1999-07-08 |
2001-01-30 |
Johnson & Johnson Consumer Companies, Inc. |
Exothermic bandage
|
US6890553B1
(en)
|
1999-07-08 |
2005-05-10 |
Johnson & Johnson Consumer Companies, Inc. |
Exothermic topical delivery device
|
US6319224B1
(en)
*
|
1999-08-20 |
2001-11-20 |
Bioject Medical Technologies Inc. |
Intradermal injection system for injecting DNA-based injectables into humans
|
AU7064700A
(en)
*
|
1999-08-20 |
2001-03-19 |
Bioject, Inc. |
Intramuscular injection system for injecting dna-based injectables into humans
|
US20050027239A1
(en)
*
|
1999-08-20 |
2005-02-03 |
Stout Richard R. |
Intradermal injection system for injecting DNA-based injectables into humans
|
EP2829609A1
(de)
|
1999-08-24 |
2015-01-28 |
E. R. Squibb & Sons, L.L.C. |
Humane Antikörper gegen CTLA-4-Antikörper und Verwendungen davon
|
US7113821B1
(en)
|
1999-08-25 |
2006-09-26 |
Johnson & Johnson Consumer Companies, Inc. |
Tissue electroperforation for enhanced drug delivery
|
US7133717B2
(en)
*
|
1999-08-25 |
2006-11-07 |
Johnson & Johnson Consumer Companies, Inc. |
Tissue electroperforation for enhanced drug delivery and diagnostic sampling
|
US6626871B1
(en)
|
1999-10-11 |
2003-09-30 |
Felton International, Inc. |
Method and apparatus for removing cap from medical device
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US6776776B2
(en)
*
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US7029457B2
(en)
*
|
1999-11-23 |
2006-04-18 |
Felton International, Inc. |
Jet injector with hand piece
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
DE60029338T2
(de)
*
|
1999-11-23 |
2007-07-12 |
Felton International, Inc., Lenexa |
Injektoranordnung mit antriebs- und verriegelungsmitteln
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
US6613026B1
(en)
|
1999-12-08 |
2003-09-02 |
Scimed Life Systems, Inc. |
Lateral needle-less injection apparatus and method
|
US6344027B1
(en)
|
1999-12-08 |
2002-02-05 |
Scimed Life Systems, Inc. |
Needle-less injection apparatus and method
|
EP1296730B2
(de)
*
|
2000-01-07 |
2014-07-30 |
Valeritas, Inc. |
Injektionsvorrichtung
|
IL151097A0
(en)
|
2000-02-23 |
2003-04-10 |
Smithkline Beecham Biolog |
Tumour-specific animal proteins
|
FR2805749B1
(fr)
*
|
2000-03-01 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille a deux niveaux de vitesse d'injection
|
US7137968B1
(en)
|
2000-03-13 |
2006-11-21 |
Nucryst Pharmaceuticals Corp. |
Transcutaneous medical device dressings and method of use
|
AU2001247721A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Antares Pharma, Inc. |
Single use disposable jet injector
|
US6719987B2
(en)
|
2000-04-17 |
2004-04-13 |
Nucryst Pharmaceuticals Corp. |
Antimicrobial bioabsorbable materials
|
FR2807946B1
(fr)
*
|
2000-04-19 |
2002-06-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant avec un chargement pyrotechnique bicomposition
|
US6716190B1
(en)
*
|
2000-04-19 |
2004-04-06 |
Scimed Life Systems, Inc. |
Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body
|
US7404815B2
(en)
*
|
2000-05-01 |
2008-07-29 |
Lifescan, Inc. |
Tissue ablation by shear force for sampling biological fluids and delivering active agents
|
US6689101B2
(en)
*
|
2000-05-22 |
2004-02-10 |
Pharmacia Ab |
Medical arrangement
|
US6406456B1
(en)
|
2000-06-08 |
2002-06-18 |
Avant Drug Delivery Systems, Inc. |
Jet injector
|
US6645169B1
(en)
*
|
2000-06-08 |
2003-11-11 |
Avant Drug Delivery Systems, Inc. |
Air-in-tip jet injector
|
DE10029325A1
(de)
|
2000-06-20 |
2002-01-03 |
Peter Lell |
Nadellose Injektionsvorrichtung mit pyrotechnischem Antrieb
|
JP2004513615A
(ja)
|
2000-06-28 |
2004-05-13 |
コリクサ コーポレイション |
肺癌の治療および診断のための組成物および方法
|
US20030180379A1
(en)
*
|
2000-07-27 |
2003-09-25 |
Burrell Robert E. |
Solutions and aerosols of metal-containing compounds
|
JP2004505057A
(ja)
|
2000-07-27 |
2004-02-19 |
ニュクリスト ファーマシューティカルズ コーポレーション |
過剰増殖性の皮膚障害および皮膚疾患の処置
|
US7001617B2
(en)
|
2001-04-23 |
2006-02-21 |
Nueryst Pharmaceuticals Corp. |
Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
|
US20030206966A1
(en)
*
|
2000-07-27 |
2003-11-06 |
Burrell Robert E. |
Methods of inducing apoptosis and modulating metalloproteinases
|
US7008647B2
(en)
|
2001-04-23 |
2006-03-07 |
Nucryst Pharmaceuticals Corp. |
Treatment of acne
|
US20040191329A1
(en)
*
|
2000-07-27 |
2004-09-30 |
Burrell Robert E. |
Compositions and methods of metal-containing materials
|
US7427416B2
(en)
*
|
2000-07-27 |
2008-09-23 |
Nucryst Pharmaceuticals Corp. |
Methods of treating conditions using metal-containing materials
|
US7255881B2
(en)
*
|
2000-07-27 |
2007-08-14 |
Nucryst Pharmaceuticals Corp. |
Metal-containing materials
|
US6989157B2
(en)
*
|
2000-07-27 |
2006-01-24 |
Nucryst Pharmaceuticals Corp. |
Dry powders of metal-containing compounds
|
US20030185901A1
(en)
|
2000-07-27 |
2003-10-02 |
Burrell Robert E. |
Methods of treating conditions with a metal-containing material
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
CA2324045A1
(fr)
*
|
2000-10-20 |
2002-04-20 |
Universite De Sherbrooke |
Seringue sans aiguille pour l'injection sous-cutanee de poudres medicamenteuses
|
FR2815544B1
(fr)
|
2000-10-23 |
2003-02-14 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille securisee a architecture compacte
|
US6652483B2
(en)
*
|
2000-11-07 |
2003-11-25 |
Avant Drug Delivery Systems, Inc. |
Needleless jet injector system with separate drug reservoir
|
US6626863B1
(en)
|
2000-11-22 |
2003-09-30 |
Nusaf, L.L.C. |
Safety syringe
|
US7931614B2
(en)
*
|
2000-11-30 |
2011-04-26 |
Valeritas, Inc. |
Injection systems
|
GB0100756D0
(en)
|
2001-01-11 |
2001-02-21 |
Powderject Res Ltd |
Needleless syringe
|
CN1286536C
(zh)
*
|
2001-01-18 |
2006-11-29 |
梅德拉股份有限公司 |
医用注射器使用的针筒托架
|
US6758837B2
(en)
|
2001-02-08 |
2004-07-06 |
Pharmacia Ab |
Liquid delivery device and method of use thereof
|
DE60239594D1
(de)
|
2001-02-23 |
2011-05-12 |
Glaxosmithkline Biolog Sa |
Influenza vakzinzusammensetzungen zur intradermaler verabreichung
|
US6645170B2
(en)
*
|
2001-03-05 |
2003-11-11 |
Bioject Medical Technologies, Inc. |
Simplified disposable needle-free injection apparatus and method
|
US6471669B2
(en)
|
2001-03-05 |
2002-10-29 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
US20020139088A1
(en)
|
2001-03-08 |
2002-10-03 |
Archie Woodworth |
Polymeric syringe body and stopper
|
US20020172615A1
(en)
*
|
2001-03-08 |
2002-11-21 |
Archie Woodworth |
Apparatus for and method of manufacturing a prefilled sterile container
|
JP2004529754A
(ja)
|
2001-03-14 |
2004-09-30 |
ペンジェット・コーポレーション |
溶液から溶解ガスを除去するためのシステムおよび方法
|
ZA200200808B
(en)
|
2001-03-22 |
2002-08-12 |
Roche Diagnostics Gmbh |
Needleless hypodermic injection system, application device and medication cartridge therefor.
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US7795218B2
(en)
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
US20050192530A1
(en)
*
|
2001-04-13 |
2005-09-01 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
US6613010B2
(en)
*
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
DE60210441T2
(de)
|
2001-04-23 |
2006-11-16 |
Nucryst Pharmaceuticals Corp., Fort Saskatchewan |
Arzneimittel oder pflaster enthaltend ein metall wie silber, gold, platin oder palladium als antimikrobiellen wirkstoff und dessen verwendung in der behandlung von hautentzündungen
|
WO2002087663A2
(en)
|
2001-04-27 |
2002-11-07 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
WO2002089747A2
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US6648850B2
(en)
*
|
2001-06-08 |
2003-11-18 |
Bioject, Inc. |
Durable needle-less jet injector apparatus and method
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
CN1253220C
(zh)
*
|
2001-06-29 |
2006-04-26 |
贝克顿迪肯森公司 |
通过微管在真皮内输入疫苗和基因治疗剂
|
US7544188B2
(en)
*
|
2001-07-19 |
2009-06-09 |
Intelliject, Inc. |
Medical injector
|
US7767872B2
(en)
*
|
2001-09-06 |
2010-08-03 |
Mpg Biotechnologies, Llc |
Thimerosal removal device
|
US8440791B2
(en)
*
|
2001-09-06 |
2013-05-14 |
Mgp Biotechnologies, Llc |
Thimerosal removal device
|
US6669664B2
(en)
|
2001-09-07 |
2003-12-30 |
Avant Drug Delivery Systems, Inc. |
Vacuum control cycle for jet injector
|
HUP0402259A3
(en)
|
2001-09-20 |
2010-01-28 |
Glaxo Group Ltd |
Vaccines
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
GB0125506D0
(en)
*
|
2001-10-24 |
2001-12-12 |
Weston Medical Ltd |
Needle free injection method and apparatus
|
PT1443992E
(pt)
*
|
2001-11-09 |
2007-02-28 |
Alza Corp |
Cartucho de seringa compressível
|
US6607510B2
(en)
|
2001-11-09 |
2003-08-19 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
PT2221076E
(pt)
*
|
2001-11-09 |
2013-07-15 |
Alza Corp |
Auto-injector pneumático
|
TWI222370B
(en)
*
|
2001-12-14 |
2004-10-21 |
Roche Diagnostics Gmbh |
Needleless hypodermic injection device
|
CA2476755C
(en)
|
2001-12-17 |
2014-08-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
AU2003209645A1
(en)
*
|
2002-03-04 |
2003-09-16 |
Nano Pass Technologies Ltd. |
Devices and methods for transporting fluid across a biological barrier
|
US6912417B1
(en)
*
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
CN1324047C
(zh)
|
2002-04-12 |
2007-07-04 |
先灵公司 |
G蛋白偶联受体的配体与方法
|
DK1503788T3
(da)
|
2002-04-25 |
2011-10-17 |
Shire Human Genetic Therapies |
Behandling af alpha-galactosidase A-deficiens
|
WO2003100008A2
(en)
|
2002-05-24 |
2003-12-04 |
Schering Corporation |
Neutralizing human anti-igfr antibody
|
US7238167B2
(en)
*
|
2002-06-04 |
2007-07-03 |
Bioject Inc. |
Needle-free injection system
|
US7156823B2
(en)
*
|
2002-06-04 |
2007-01-02 |
Bioject Inc. |
High workload needle-free injection system
|
US6676630B2
(en)
|
2002-06-04 |
2004-01-13 |
Bioject Medical Technologies, Inc. |
Needle-free injection system
|
US20040132058A1
(en)
|
2002-07-19 |
2004-07-08 |
Schering Corporation |
NPC1L1 (NPC3) and methods of use thereof
|
US6883222B2
(en)
*
|
2002-10-16 |
2005-04-26 |
Bioject Inc. |
Drug cartridge assembly and method of manufacture
|
SI1558648T1
(sl)
|
2002-10-17 |
2012-05-31 |
Genmab As |
Človeška monoklonalna protitelesa proti CD
|
CA2500829A1
(en)
*
|
2002-10-22 |
2004-05-06 |
Nucryst Pharmaceuticals Corp. |
Prophylactic treatment methods
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
AU2003275895B2
(en)
|
2002-11-25 |
2009-02-05 |
Tecpharma Licensing Ag |
Auto-injector comprising a resettable releasing safety device
|
RU2389732C2
(ru)
|
2003-01-06 |
2010-05-20 |
Корикса Корпорейшн |
Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
ES2362424T3
(es)
|
2003-01-07 |
2011-07-05 |
Dyax Corporation |
Biblioteca del dominio kunitz.
|
CA2814767C
(en)
|
2003-01-31 |
2016-03-15 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiency disorders
|
US6935384B2
(en)
*
|
2003-02-19 |
2005-08-30 |
Bioject Inc. |
Needle-free injection system
|
FR2852517B1
(fr)
*
|
2003-03-21 |
2005-11-11 |
|
Dispositif d'injection sans aiguille a cartouche pyrotechnique et procede d'assemblage d'un tel dispositif
|
JP2006524120A
(ja)
*
|
2003-04-21 |
2006-10-26 |
ストラテージェント ライフ サイエンシズ |
マイクロジェットで反復的に薬物を搬送する装置および方法
|
US20060184101A1
(en)
*
|
2003-04-21 |
2006-08-17 |
Ravi Srinivasan |
Microjet devices and methods for drug delivery
|
NZ542988A
(en)
|
2003-04-23 |
2008-07-31 |
Medarex Inc |
Humanised antibodies directed against the IFNAR-1 receptor in which murine CDR sequences have been grafted directly into unmodified human framework sequences, resulting in high affinity, functional antibodies
|
WO2004110533A1
(ja)
*
|
2003-05-09 |
2004-12-23 |
Anges Mg, Inc. |
薬剤が収容された針無注射器
|
AU2004272972A1
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
WO2005034949A1
(en)
*
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
IL157981A
(en)
|
2003-09-17 |
2014-01-30 |
Elcam Medical Agricultural Cooperative Ass Ltd |
Auto injector
|
GB0325836D0
(en)
*
|
2003-11-05 |
2003-12-10 |
Celltech R&D Ltd |
Biological products
|
JP4833850B2
(ja)
|
2003-11-21 |
2011-12-07 |
ユセベ ファルマ ソシエテ アノニム |
Il−17活性阻害による多発性硬化症を治療するための方法
|
EA008731B1
(ru)
*
|
2003-11-21 |
2007-08-31 |
Чжуншань Ботай Фармасьютик Инструментс Ко., Лтд. |
Шприц типа предварительного смешивания порошкового лекарства
|
PL1691837T3
(pl)
|
2003-12-10 |
2012-11-30 |
Squibb & Sons Llc |
IP-10 przeciwciała i ich zastosowanie
|
CA2546054C
(en)
|
2003-12-10 |
2014-05-13 |
Medarex, Inc. |
Interferon alpha antibodies and their uses
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
EP3466483A1
(de)
|
2004-03-08 |
2019-04-10 |
Ichor Medical Systems Inc. |
Verbessertes gerät für die elektrisch vermittelte abgabe von therapeutika
|
IL160891A0
(en)
|
2004-03-16 |
2004-08-31 |
|
Auto-mix needle
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
RU2006138704A
(ru)
*
|
2004-05-19 |
2008-06-27 |
Вайет (Us) |
Модуляция производства иммуноглобулина и атопические расстройства
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
CA2570823C
(en)
|
2004-06-21 |
2015-02-24 |
Medarex, Inc. |
Interferon alpha receptor 1 antibodies and their uses
|
JP2008515774A
(ja)
|
2004-08-03 |
2008-05-15 |
ダイアックス コーポレイション |
hK1結合タンパク質
|
GB0417852D0
(en)
|
2004-08-11 |
2004-09-15 |
Biotica Tech Ltd |
Production of polyketides and other natural products
|
US20060040895A1
(en)
*
|
2004-08-19 |
2006-02-23 |
Kipling Thacker |
Aesthetic use of hyaluronan
|
CA2478458A1
(en)
*
|
2004-08-20 |
2006-02-20 |
Michael Panzara |
Treatment of pediatric multiple sclerosis
|
EP1793849A2
(de)
|
2004-09-22 |
2007-06-13 |
GlaxoSmithKline Biologicals SA |
Immunogene zusammensetzung zur verwendung bei der impfung gegen staphylokokken
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
JP2008518629A
(ja)
|
2004-11-08 |
2008-06-05 |
シェーリング コーポレイション |
Mdl−1の腫瘍との関連およびその方法
|
WO2006050611A1
(en)
|
2004-11-12 |
2006-05-18 |
The University Of British Columbia |
Antimicrobial peptides
|
AU2005306399B2
(en)
|
2004-11-19 |
2012-02-09 |
Biogen Ma Inc. |
Treatment for multiple sclerosis
|
US7648483B2
(en)
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US11590286B2
(en)
|
2004-11-22 |
2023-02-28 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
US7947017B2
(en)
|
2004-11-22 |
2011-05-24 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US7648482B2
(en)
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems, and methods for medicament delivery
|
CA2586525C
(en)
*
|
2004-11-22 |
2013-01-15 |
Intelliject, Llc |
Devices, systems, and methods for medicament delivery
|
US10737028B2
(en)
|
2004-11-22 |
2020-08-11 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
JP4904283B2
(ja)
*
|
2004-12-01 |
2012-03-28 |
アキュショット インク |
無針注射器
|
NZ581497A
(en)
*
|
2004-12-03 |
2012-07-27 |
Biogen Idec Inc |
Delaying or preventing onset of multiple sclerosis by vla-4 ginding antibody
|
WO2006060419A2
(en)
|
2004-12-03 |
2006-06-08 |
Schering Corporation |
Biomarkers for pre-selection of patients for anti-igf1r therapy
|
US7351226B1
(en)
*
|
2004-12-07 |
2008-04-01 |
Glenn Herskowitz |
Medical infusion pump
|
EP1841866B1
(de)
*
|
2005-01-25 |
2009-04-22 |
Sky Genetics, Inc. |
Nukleinsäuren für die apoptose von krebszellen
|
US20060183893A1
(en)
*
|
2005-01-25 |
2006-08-17 |
North Don A |
Nucleic acids for apoptosis of cancer cells
|
US8361026B2
(en)
|
2005-02-01 |
2013-01-29 |
Intelliject, Inc. |
Apparatus and methods for self-administration of vaccines and other medicaments
|
US7731686B2
(en)
|
2005-02-01 |
2010-06-08 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US8206360B2
(en)
|
2005-02-01 |
2012-06-26 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US9022980B2
(en)
|
2005-02-01 |
2015-05-05 |
Kaleo, Inc. |
Medical injector simulation device
|
US8231573B2
(en)
|
2005-02-01 |
2012-07-31 |
Intelliject, Inc. |
Medicament delivery device having an electronic circuit system
|
NZ560516A
(en)
|
2005-02-01 |
2010-12-24 |
Intelliject Inc |
A delivery system where a medicant is automatically delivered on activation as well as a recorded instruction
|
US20090124993A1
(en)
|
2005-02-17 |
2009-05-14 |
Burkly Linda C |
Treating neurological disorders
|
US8207303B2
(en)
|
2005-02-18 |
2012-06-26 |
Medarex, Inc. |
Monoclonal antibodies against CD30 lacking in fucosyl residues
|
GB0504994D0
(en)
*
|
2005-03-11 |
2005-04-20 |
Biotica Tech Ltd |
Novel compounds
|
US20100061994A1
(en)
*
|
2005-03-11 |
2010-03-11 |
Rose Mary Sheridan |
Medical uses of 39-desmethoxyrapamycin and analogues thereof
|
SG10201912554TA
(en)
|
2005-03-23 |
2020-02-27 |
Genmab As |
Antibodies against cd38 for treatment of multiple myeloma
|
PE20061428A1
(es)
|
2005-03-23 |
2007-01-16 |
Glaxosmithkline Biolog Sa |
Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
|
CN101189023B
(zh)
|
2005-03-31 |
2013-01-30 |
通用医疗公司 |
监测和调制hgf/hgfr活性
|
ES2732625T3
(es)
|
2005-04-04 |
2019-11-25 |
Univ Florida |
Análogos de poliéter de desferritiocina
|
LT2439273T
(lt)
|
2005-05-09 |
2019-05-10 |
Ono Pharmaceutical Co., Ltd. |
Žmogaus monokloniniai antikūnai prieš programuotos mirties 1(pd-1) baltymą, ir vėžio gydymo būdai, naudojant vien tik anti-pd-1 antikūnus arba derinyje su kitais imunoterapiniais vaistais
|
KR20080025373A
(ko)
|
2005-05-17 |
2008-03-20 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
1-데옥시노지리마이신 및 유도체를 이용한 폼페병의 치료방법
|
CN102441163A
(zh)
|
2005-05-27 |
2012-05-09 |
比奥根艾迪克Ma公司 |
结合tweak的抗体
|
US20060271014A1
(en)
*
|
2005-05-31 |
2006-11-30 |
Mallinckrodt Inc. |
Heat retention device for a syringe and methods of use
|
US20070118093A1
(en)
*
|
2005-06-20 |
2007-05-24 |
Von Muhlen Marcio G |
High-speed jet devices for drug delivery
|
CN105330741B
(zh)
|
2005-07-01 |
2023-01-31 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
WO2007016643A2
(en)
*
|
2005-08-01 |
2007-02-08 |
Mount Sinai School Of Medicine Of New York University |
A method for extending longevity using npc1l1 antagonists
|
EP1919504B1
(de)
*
|
2005-08-03 |
2013-10-16 |
iBio, Inc. |
Antikörper gegen bacillus anthracis protektiv antigen
|
US20070055199A1
(en)
*
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Drug delivery device for buccal and aural applications and other areas of the body difficult to access
|
EP1762575A1
(de)
*
|
2005-09-12 |
2007-03-14 |
Ganymed Pharmaceuticals AG |
Identifizierung Tumor-assoziierter Antigene für Diagnoseund Therapie
|
EP1934261B1
(de)
|
2005-09-26 |
2014-10-29 |
Medarex, L.L.C. |
Humane monoklonale antikörper gegen cd70
|
EP2532679B1
(de)
|
2005-10-21 |
2017-04-12 |
Novartis AG |
Menschliche Antikörper gegen IL13 und therapeutische Verwendungen
|
US20070099246A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Sandy John D |
Antibodies, assays and kits to quantitate cartilage destruction
|
EP3058972A1
(de)
|
2005-11-17 |
2016-08-24 |
Zogenix, Inc. |
Abgabe von viskosen formulierungen durch nadellose injektion
|
EP1790664A1
(de)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
|
EA013338B1
(ru)
*
|
2005-12-05 |
2010-04-30 |
Чжуншань Ботай Фармасьютик Инструментс Ко., Лтд. |
Автоматический шприц
|
PT1960434E
(pt)
|
2005-12-08 |
2012-10-02 |
Medarex Inc |
Anticorpos monoclonais humanos para fucosil-gm1 e métodos para a utilização de anti-fucosil-gm1
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JO2813B1
(en)
|
2005-12-22 |
2014-09-15 |
جلاكسو سميث كلاين بايولوجيكالز اس.ايه |
A vaccine with multiple pneumococcal saccharides
|
US20090081157A1
(en)
|
2006-01-09 |
2009-03-26 |
Richard Syd Kornbluth |
Immunostimulatory Combinations for Vaccine Adjuvants
|
US20070166774A1
(en)
*
|
2006-01-17 |
2007-07-19 |
Groman Ernest V |
Functional immunoassay
|
DK1986612T3
(da)
|
2006-02-07 |
2012-10-29 |
Shire Human Genetic Therapies |
Stabiliserede proteinsammensætninger med en fri thioldel
|
EP2335754B1
(de)
*
|
2006-02-09 |
2013-12-18 |
DEKA Products Limited Partnership |
Systeme zur Abgabe von Flüssigkeiten in patch-grösse
|
JP2009526526A
(ja)
*
|
2006-02-13 |
2009-07-23 |
フラウンホーファー ユーエスエー, インコーポレイテッド |
インフルエンザ抗原、ワクチン組成物、および関連する方法
|
US20080279877A1
(en)
*
|
2006-02-13 |
2008-11-13 |
Fraunhofer U.S.A. Inc. |
HPV antigens, vaccine compositions, and related methods
|
US8277816B2
(en)
*
|
2006-02-13 |
2012-10-02 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
CA2642540C
(en)
*
|
2006-02-17 |
2015-11-24 |
Alan L. Buchman |
Catheter cleaning devices
|
EP1998684A4
(de)
*
|
2006-03-10 |
2014-09-17 |
Massachusetts Inst Technology |
Konjugate und nanosysteme mit ausgelöstem selbstzusammenbau
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
US20080045471A1
(en)
*
|
2006-03-27 |
2008-02-21 |
North Don A |
Nucleic Acids For Apoptosis Of Cancer Cells
|
MX337528B
(es)
|
2006-03-30 |
2016-03-09 |
Glaxosmithkline Biolog Sa |
Composición inmunogénica que comprende un sacárido capsular estafilocócico o-acetilado y una proteína estafilocócica.
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
WO2007120638A2
(en)
*
|
2006-04-12 |
2007-10-25 |
President And Fellows Of Harvard College |
Methods and compositions for modulating glycosylation
|
EP2021030A2
(de)
*
|
2006-04-21 |
2009-02-11 |
Amgen, Inc. |
Puffermittel für biopharmazeutische formulierungen
|
US20070258941A1
(en)
*
|
2006-05-02 |
2007-11-08 |
Pfister Brian E |
Methods and compositions for remediation of disc herniation by modifying structure
|
WO2007133807A2
(en)
|
2006-05-15 |
2007-11-22 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
US10119979B2
(en)
|
2006-05-25 |
2018-11-06 |
Biogen Ma Inc. |
Methods of treating stroke and traumatic brain injury using humanized AQC2 anti-VLA-1 antibodies
|
WO2007143574A1
(en)
*
|
2006-06-02 |
2007-12-13 |
President And Fellows Of Harvard College |
Protein surface remodeling
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
EP2032989B2
(de)
|
2006-06-30 |
2015-10-28 |
Merck Sharp & Dohme Corp. |
Igfbp2-biomarker
|
EP2046383B1
(de)
|
2006-07-04 |
2014-11-19 |
Genmab A/S |
Cd20-bindungsmoleküle zur behandlung von copd
|
SI2422810T1
(sl)
|
2006-07-17 |
2015-01-30 |
Glaxosmithkline Biologicals S.A. |
Influenčno cepivo
|
US20080033347A1
(en)
*
|
2006-08-03 |
2008-02-07 |
Becton, Dickinson And Company |
Detachable needle syringe having reduced dead space
|
US7618396B2
(en)
*
|
2006-08-09 |
2009-11-17 |
Avant Medical Corp. |
Injection system with hidden needles
|
WO2008018641A1
(en)
|
2006-08-11 |
2008-02-14 |
Ono Pharmaceutical Co., Ltd. |
Monoclonal antibodies against stromal derived factor-1 (sdf-1)
|
US9115358B2
(en)
*
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
KR20090050056A
(ko)
*
|
2006-08-14 |
2009-05-19 |
메사츄세츠 인스티튜트 어브 테크놀로지 |
헤마글루티닌 폴리펩티드 및 시약 그리고 방법
|
US20110182904A1
(en)
|
2006-09-05 |
2011-07-28 |
Deborah Zimmerman |
Antibodies to bone morphogenic proteins and receptors therefor and methods for their use
|
US7942845B2
(en)
*
|
2006-09-19 |
2011-05-17 |
Bioject, Inc. |
Needle-free injector and process for providing serial injections
|
SG178712A1
(en)
|
2006-10-02 |
2012-03-29 |
Medarex Inc |
Human antibodies that bind cxcr4 and uses thereof
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
EP2081553B1
(de)
*
|
2006-10-06 |
2020-08-12 |
Amgen Inc. |
Stabile antikörper-formulierungen
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
EP2433648A3
(de)
|
2006-10-12 |
2012-04-04 |
GlaxoSmithKline Biologicals S.A. |
Impfstoff mit einem Öl-in-wasser-emulsionshilfsstoff
|
BRPI0717219B8
(pt)
|
2006-10-12 |
2021-05-25 |
Glaxosmithkline Biologicals Sa |
composição imunogênica, e, uso de uma composição imunogênica
|
ES2388567T3
(es)
|
2006-10-19 |
2012-10-16 |
Csl Limited |
Anticuerpos anti-il-13r alfa 1 y usos de los mismos
|
EP2094247B1
(de)
*
|
2006-10-20 |
2022-06-29 |
Amgen Inc. |
Stabile polypeptid-formulierungen
|
EP2311481A3
(de)
|
2006-10-20 |
2013-10-16 |
Biogen Idec MA Inc. |
Behandlung von Entmarkungserkrankungen mit löslichem Lymphotoxin-beta-rezeptor
|
US8618248B2
(en)
|
2006-10-31 |
2013-12-31 |
President And Fellows Of Harvard College |
Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides
|
US20090124996A1
(en)
*
|
2006-11-03 |
2009-05-14 |
Scott Heneveld |
Apparatus and methods for injecting high viscosity dermal fillers
|
MX2009005189A
(es)
|
2006-11-15 |
2009-06-30 |
Medarex Inc |
Anticuerpos humanos monoclonales para btla y metodos de uso.
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
CN101848702B
(zh)
|
2006-12-01 |
2013-07-17 |
安特里奥公司 |
两亲实体纳米粒子
|
MX2009005776A
(es)
|
2006-12-01 |
2009-06-10 |
Medarex Inc |
Anticuerpos humanos que se enlazan al cd 22 y sus usos.
|
WO2008073856A2
(en)
*
|
2006-12-08 |
2008-06-19 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
CL2007003622A1
(es)
|
2006-12-13 |
2009-08-07 |
Medarex Inc |
Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
|
WO2008074004A2
(en)
|
2006-12-14 |
2008-06-19 |
Medarex, Inc. |
Human antibodies that bind cd70 and uses thereof
|
CA2790018C
(en)
*
|
2006-12-21 |
2015-02-03 |
Amgen Inc. |
Formulations
|
CN110003079A
(zh)
|
2006-12-26 |
2019-07-12 |
兰休斯医疗成像公司 |
用于使心脏神经支配成像的配体
|
EP2104525A4
(de)
*
|
2006-12-29 |
2010-12-29 |
Amir Genosar |
Hypodermes arzneiabgabereservoir und gerät
|
EP2125075A2
(de)
|
2007-01-22 |
2009-12-02 |
Intelliject, Inc. |
Medizinischer injektor mit konformitätsverfolgung und -überwachung
|
AU2008210434C8
(en)
|
2007-01-31 |
2014-03-27 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
PL2716301T3
(pl)
|
2007-02-16 |
2017-10-31 |
Merrimack Pharmaceuticals Inc |
Przeciwciała przeciw ERBB3 i ich zastosowania
|
WO2008103997A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Needle-free injection devices and drug delivery systems therefor
|
EP1970384A1
(de)
*
|
2007-03-14 |
2008-09-17 |
Ganymed Pharmaceuticals AG |
Monoklonale Antikörper zur Krebsbehandlung
|
AU2008229472B2
(en)
|
2007-03-15 |
2013-03-14 |
University Of Florida Research Foundation, Inc. |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
JP5779350B2
(ja)
|
2007-03-27 |
2015-09-16 |
シー レーン バイオテクノロジーズ, エルエルシー |
抗体代替軽鎖配列を含む構築物およびライブラリー
|
BRPI0809366B8
(pt)
|
2007-03-28 |
2021-05-25 |
Harvard College |
polipeptídeo substancialmente alfa-helicoidal, método para fabricação do mesmo, aminoácido e composição farmacêutica
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ(アミノ酸)ターゲッティング部分
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
WO2008134643A2
(en)
*
|
2007-04-28 |
2008-11-06 |
Fraunhofer Usa, Inc. |
Trypanosoma antigens, vaccine compositions, and related methods
|
GB0708758D0
(en)
|
2007-05-04 |
2007-06-13 |
Powderject Res Ltd |
Particle cassettes and process thereof
|
WO2008148057A2
(en)
|
2007-05-23 |
2008-12-04 |
Vical Incorporated |
Cationic lipids compositions and methods for enhancing immune responses to vaccines
|
EP1997832A1
(de)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
|
WO2008153926A2
(en)
|
2007-06-05 |
2008-12-18 |
Yale University |
Inhibitors of receptor tyrosine kinases and methods of use thereof
|
CN103977404A
(zh)
*
|
2007-06-14 |
2014-08-13 |
比奥根艾迪克Ma公司 |
抗体制剂
|
CN101754770B
(zh)
*
|
2007-06-14 |
2015-05-20 |
克鲁塞尔瑞士股份公司 |
皮内流感疫苗
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
PT2167121E
(pt)
|
2007-06-26 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae
|
WO2009009759A2
(en)
|
2007-07-11 |
2009-01-15 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
DE102007034871A1
(de)
*
|
2007-07-24 |
2009-01-29 |
Lts Lohmann Therapie-Systeme Ag |
Einweginjektor mit handbetätigbarem Kolben
|
US9693539B2
(en)
|
2007-08-10 |
2017-07-04 |
E. R. Squibb & Sons, L.L.C. |
HCO32 and HCO27 and related examples
|
US20110059130A1
(en)
*
|
2007-08-20 |
2011-03-10 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
|
US8415455B2
(en)
|
2007-09-04 |
2013-04-09 |
Compugen Ltd |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
GB0717337D0
(en)
|
2007-09-06 |
2007-10-17 |
Ucb Pharma Sa |
Method of treatment
|
WO2009046314A2
(en)
*
|
2007-10-04 |
2009-04-09 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
US10736848B2
(en)
|
2007-10-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
AR068767A1
(es)
|
2007-10-12 |
2009-12-02 |
Novartis Ag |
Anticuerpos contra esclerostina, composiciones y metodos de uso de estos anticuerpos para tratar un trastorno patologico mediado por esclerostina
|
EP2215269B1
(de)
*
|
2007-10-15 |
2017-12-13 |
Admedus Vaccines Pty Limited |
Konstruktsystem und verwendungen dafür
|
DK2567709T3
(en)
|
2007-11-02 |
2018-03-12 |
Novartis Ag |
Molecules and Methods for Modulating Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6)
|
NZ585556A
(en)
|
2007-11-07 |
2012-07-27 |
Celldex Therapeutics Inc |
Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
|
US8617099B2
(en)
*
|
2007-11-26 |
2013-12-31 |
Bioject Inc. |
Injection device plunger auto-disable
|
US20090137949A1
(en)
*
|
2007-11-26 |
2009-05-28 |
Bioject Inc. |
Needle-free injection device with nozzle auto-disable
|
EP2231705A2
(de)
|
2007-12-17 |
2010-09-29 |
Pfizer Limited |
Behandlung von interstitieller cystitis
|
WO2009086250A1
(en)
|
2007-12-21 |
2009-07-09 |
Aesthetic Sciences Corporation |
Self-contained pressurized injection device
|
CN101951988A
(zh)
|
2007-12-28 |
2011-01-19 |
阿克蒂弗派克股份有限公司 |
适合用于将治疗物质给予对象的分配器和治疗包装
|
DE102008011873A1
(de)
|
2007-12-30 |
2009-07-09 |
Idelevich, Evgeny |
Applikationsvorrichtung und -verfahren zur automatisierten Medikamentenabgabe bei arteriellem Hypertonus
|
CN101951927A
(zh)
*
|
2008-01-03 |
2011-01-19 |
麻省理工学院 |
诱饵流感疗法
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
KR101588309B1
(ko)
|
2008-01-22 |
2016-01-25 |
푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬 |
펩티드, 조성물 및 그의 용도
|
US8039596B2
(en)
|
2008-02-05 |
2011-10-18 |
Bristol-Myers Squibb Company |
Alpha 5-beta 1 antibodies and their uses
|
CN101952454B
(zh)
|
2008-02-08 |
2014-06-04 |
米迪缪尼有限公司 |
具有减弱的Fc配体亲和性的抗IFNAR1抗体
|
AR072249A1
(es)
*
|
2008-04-09 |
2010-08-18 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso. usos. metodos.
|
AU2009237647A1
(en)
|
2008-04-16 |
2009-10-22 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
EP2829265B1
(de)
*
|
2008-04-28 |
2016-08-24 |
Zogenix, Inc. |
Neuartige Formulierungen zur Behandlung von Migräne
|
AU2009243187C1
(en)
*
|
2008-04-28 |
2015-12-24 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
EP2274331B1
(de)
|
2008-05-02 |
2013-11-06 |
Novartis AG |
Verbesserte bindemoleküle auf fibronectin-basis und ihre verwendung
|
USD994111S1
(en)
|
2008-05-12 |
2023-08-01 |
Kaleo, Inc. |
Medicament delivery device cover
|
US8021344B2
(en)
|
2008-07-28 |
2011-09-20 |
Intelliject, Inc. |
Medicament delivery device configured to produce an audible output
|
CA2725911A1
(en)
|
2008-05-30 |
2009-12-23 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating a meiotic kinesin-associated disease
|
JP2011521744A
(ja)
*
|
2008-05-30 |
2011-07-28 |
アラーガン、インコーポレイテッド |
軟質組織増強充填剤、生物活性剤および液状又はゲル状の他の生体適合材料を注入するための注入装置
|
WO2009150623A1
(en)
|
2008-06-13 |
2009-12-17 |
Pfizer Inc |
Treatment of chronic prostatitis
|
JP6146949B2
(ja)
|
2008-06-20 |
2017-06-21 |
ノバルティス アーゲー |
凝集が低減された免疫グロブリン
|
BRPI0914630A2
(pt)
|
2008-06-26 |
2019-09-24 |
Anterios Inc |
liberação dérmica
|
JP5986745B2
(ja)
|
2008-07-15 |
2016-09-06 |
アカデミア シニカAcademia Sinica |
Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
|
AU2009274571A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Massachusetts Institute Of Technology |
Activation of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival
|
EP2356139A4
(de)
|
2008-07-23 |
2013-01-09 |
Harvard College |
Ligieren zusammengehefteter polypeptide
|
EP2316030B1
(de)
|
2008-07-25 |
2019-08-21 |
Wagner, Richard W. |
Proteinscreeningverfahren
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
EP2166021A1
(de)
|
2008-09-16 |
2010-03-24 |
Ganymed Pharmaceuticals AG |
Monoklonale Antikörper zur Krebsbehandlung
|
ES2824839T3
(es)
*
|
2008-09-18 |
2021-05-13 |
Becton Dickinson Co |
Inyector médico con activación de manguito deslizante
|
ES2592216T3
(es)
|
2008-09-26 |
2016-11-28 |
Dana-Farber Cancer Institute, Inc. |
Anticuerpos anti-PD-1, PD-L1 y PD-L2 humanos y sus usos
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
KR101581986B1
(ko)
|
2008-10-29 |
2016-01-04 |
아블린쓰 엔.브이. |
단일 도메인 항원 결합 분자의 제형
|
WO2010057197A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
US9545483B2
(en)
*
|
2008-12-02 |
2017-01-17 |
Sanofi-Aventis Deutschland Gmbh |
Drive assembly suitable for use in a medication delivery device and medication delivery device
|
CA2743583C
(en)
|
2008-12-02 |
2016-11-15 |
Allergan, Inc. |
Injection device
|
AU2009325878B2
(en)
|
2008-12-08 |
2014-01-16 |
Compugen Ltd. |
TMEM154 polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
WO2010067345A1
(en)
*
|
2008-12-08 |
2010-06-17 |
Perf-Action Technologies Ltd. |
Erosion prevention for o-rings in a high pressure injection device
|
EP2376619A4
(de)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
Verfahren zur flusssteuerung bei stoffwechselwegen
|
WO2010069605A2
(en)
|
2008-12-19 |
2010-06-24 |
Medirista Biotechnologies Ab |
Oxidized cardiolipin as a novel pro-inflammatory factor
|
CN105132387A
(zh)
*
|
2008-12-22 |
2015-12-09 |
绿光生物科学公司 |
用于制造化合物的组合物和方法
|
BRPI1009232B1
(pt)
|
2009-03-05 |
2022-05-03 |
E.R. Squibb & Sons, Llc. |
Anticorpo monoclonal isolado ou uma porção de ligação de antígeno do mesmo, ou um fragmento de anticorpo, composição que os compreende, molécula de ácido nucleico, hibridoma e métodos para a preparação de um anticorpo anti-cadm1
|
GB0904540D0
(en)
|
2009-03-17 |
2009-04-29 |
Biotica Tech Ltd |
Novel compounds and methods for their production
|
AU2010234449A1
(en)
|
2009-04-07 |
2011-11-03 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
EP2416660B1
(de)
|
2009-04-07 |
2014-07-02 |
Infinity Pharmaceuticals, Inc. |
Fettsäureamidhydrolase-hemmer
|
CN102625661B
(zh)
|
2009-04-09 |
2015-05-27 |
阿米库斯治疗学公司 |
用于预防和/或治疗溶酶体贮积失调的方法
|
AU2010236257A1
(en)
*
|
2009-04-17 |
2011-11-03 |
Biogen Idec Ma Inc. |
Compositions and methods to treat acute myelogenous leukemia
|
SG10201401604VA
(en)
|
2009-04-20 |
2014-08-28 |
Oxford Biotherapeutics Ltd |
Antibodies Specific To Cadherin-17
|
EP2243505B1
(de)
*
|
2009-04-23 |
2018-02-14 |
Bayer Healthcare LLC |
Spritzenbaugruppen, Verfahren zum Bilden von Spritzenbaugruppen
|
JP5766179B2
(ja)
|
2009-04-27 |
2015-08-19 |
ノバルティス アーゲー |
筋肉増殖を増加させるための組成物および方法
|
MX2011011338A
(es)
|
2009-04-27 |
2012-04-19 |
Novartis Ag |
Composiciones y metodos de uso para anticuerpos terapeuticos especificos para la subunidad beta1 del receptor de il-12.
|
US9221886B2
(en)
|
2009-04-28 |
2015-12-29 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
UY32608A
(es)
|
2009-05-04 |
2010-12-31 |
Pangenetics 110 B V |
Anticuerpos contra el factor de crecimiento nervioso (ngf) con una estabilidad in vivo mejorada
|
US20120128671A1
(en)
|
2009-05-13 |
2012-05-24 |
Lawrence Horowitz |
Neutralizing molecules to influenza viruses
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
EP2438046A4
(de)
|
2009-06-01 |
2013-04-17 |
Harvard College |
O-glcnac-transferasehemmer und verwendungen davon
|
WO2010141430A2
(en)
|
2009-06-01 |
2010-12-09 |
Shriners Hospitals For Children |
A cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
|
US8974423B2
(en)
*
|
2009-06-01 |
2015-03-10 |
Sanofi-Aventis Deutschland Gmbh |
Resettable drug delivery device
|
EP3248619A3
(de)
|
2009-06-04 |
2018-03-07 |
Novartis AG |
Verfahren zur identifizierung von stellen zur igg-konjugation
|
WO2010146511A1
(en)
|
2009-06-17 |
2010-12-23 |
Pfizer Limited |
Treatment of overactive bladder
|
AU2010273220B2
(en)
|
2009-07-13 |
2015-10-15 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
KR20120090037A
(ko)
|
2009-07-31 |
2012-08-16 |
메다렉스, 인코포레이티드 |
Btla에 대한 완전 인간 항체
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB0914589D0
(en)
|
2009-08-20 |
2009-09-30 |
Biotica Tech Ltd |
Novel compounds and methods for their production
|
WO2011029823A1
(en)
|
2009-09-09 |
2011-03-17 |
Novartis Ag |
Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
GB0916630D0
(en)
|
2009-09-22 |
2009-11-04 |
Secr Defence |
Antibody
|
EP2483307A1
(de)
|
2009-09-29 |
2012-08-08 |
Fraunhofer USA, Inc. |
Influenza-hämagglutinin-antikörper, zusammensetzungen daraus und zugehörige verfahren
|
GB0917816D0
(en)
|
2009-10-12 |
2009-11-25 |
Biotica Tech Ltd |
Novel compounds and methods for their production
|
GB0917817D0
(en)
|
2009-10-12 |
2009-11-25 |
Biotica Tech Ltd |
Novel compounds and methods for their production
|
EP2470569A1
(de)
|
2009-10-13 |
2012-07-04 |
Oxford Biotherapeutics Ltd. |
Antikörper gegen epha10
|
EP2488199A1
(de)
|
2009-10-14 |
2012-08-22 |
Merrimack Pharmaceuticals, Inc. |
Auf igf-1r- und erbb3-signalisierung gerichtete bispezfische bindemittel und ihre verwendung
|
JP5805649B2
(ja)
|
2009-10-19 |
2015-11-04 |
アミカス セラピューティックス インコーポレイテッド |
中枢神経系の変性障害を予防および/または治療するための新規の組成物
|
RU2016103139A
(ru)
|
2009-10-19 |
2018-11-22 |
Амикус Терапьютикс, Инк. |
Новые композиции для предупреждения и/или лечения лизосомных болезней накопления
|
WO2011051327A2
(en)
|
2009-10-30 |
2011-05-05 |
Novartis Ag |
Small antibody-like single chain proteins
|
WO2011051466A1
(en)
|
2009-11-02 |
2011-05-05 |
Novartis Ag |
Anti-idiotypic fibronectin-based binding molecules and uses thereof
|
EP2496944A2
(de)
|
2009-11-05 |
2012-09-12 |
Novartis AG |
Prädiktive biomarker für die progression von fibrose
|
US9428586B2
(en)
|
2009-12-01 |
2016-08-30 |
Compugen Ltd |
Heparanase splice variant
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US20110137260A1
(en)
|
2009-12-07 |
2011-06-09 |
Allergan, Inc. |
Slotted syringe
|
US8293718B2
(en)
|
2009-12-18 |
2012-10-23 |
Novartis Ag |
Organic compositions to treat HSF1-related diseases
|
CA2785139A1
(en)
|
2009-12-22 |
2011-06-30 |
Novartis Ag |
Tetravalent cd47-antibody constant region fusion protein for use in therapy
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
EP2528615B1
(de)
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Manipulierte polypeptidmittel für gezielte influenza-neutralisierung in einem breiten spektrum
|
WO2011092233A1
(en)
|
2010-01-29 |
2011-08-04 |
Novartis Ag |
Yeast mating to produce high-affinity combinations of fibronectin-based binders
|
CN102834401B
(zh)
|
2010-02-03 |
2016-08-24 |
无限药品股份有限公司 |
脂肪酸酰胺水解酶抑制剂
|
MX2012009318A
(es)
|
2010-02-10 |
2012-09-07 |
Novartis Ag |
Metodos y compuestos para el crecimiento muscular.
|
CN102844023B
(zh)
|
2010-03-08 |
2016-01-20 |
索隆-基特林癌症研究协会 |
Cdc7激酶抑制剂以及其用途
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
US20110256135A1
(en)
|
2010-03-17 |
2011-10-20 |
Wolfgang Fraunhofer |
Anti-nerve growth factor (ngf) antibody compositions
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
EP2371864A1
(de)
|
2010-03-23 |
2011-10-05 |
Ganymed Pharmaceuticals AG |
Monoklonale Antikörper zur Krebsbehandlung
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9631018B2
(en)
|
2010-03-26 |
2017-04-25 |
The Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
BR112012026227A2
(pt)
|
2010-04-13 |
2020-08-04 |
Celldex Therapeutics, Inc. |
anticorpo monoclonal humano ou humanizado, molécula biespecífica, vetor de expressão, célula transformada, composição, e, usos de um anticorpo
|
SG10201502967RA
(en)
|
2010-04-16 |
2015-05-28 |
Biogen Ma Inc |
Anti-vla-4 antibodies
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
KR20220008383A
(ko)
|
2010-04-23 |
2022-01-20 |
애로우헤드 파마슈티컬스 인코포레이티드 |
베타-ENaC-관련 질환을 치료하기 위한 유기 조성물
|
MX2012012441A
(es)
|
2010-05-04 |
2013-02-26 |
Merrimack Pharmaceuticals Inc |
Anticuerpos contra el receptor del factor de crecimiento epidermico (egfr) y usos de los mismos.
|
WO2011140151A1
(en)
|
2010-05-04 |
2011-11-10 |
Dyax Corp. |
Antibodies against epidermal growth factor receptor (egfr)
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
WO2011140516A2
(en)
|
2010-05-07 |
2011-11-10 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
BR122020018186B1
(pt)
|
2010-05-11 |
2021-07-27 |
Lantheus Medical Imaging, Inc |
Uso de agentes de imagiologia para preparação de uma composição para detecção do transportador de norepinefrina (net) e método para a detecção de net
|
ES2587180T3
(es)
|
2010-05-19 |
2016-10-21 |
Allergan, Inc. |
Dispositivo de inyección modular
|
ES2664872T3
(es)
|
2010-06-18 |
2018-04-23 |
Taiho Pharmaceutical Co., Ltd |
Moduladores PRPK-TPRKB y sus usos
|
WO2016030888A1
(en)
|
2014-08-26 |
2016-03-03 |
Compugen Ltd. |
Polypeptides and uses thereof as a drug for treatment of autoimmune disorders
|
CN107441480A
(zh)
|
2010-06-30 |
2017-12-08 |
卡姆普根有限公司 |
多肽及其作为用于治疗多发性硬化、类风湿性关节炎以及其他自身免疫病症的药物的用途
|
CA2804154C
(en)
|
2010-07-01 |
2021-06-01 |
The Texas A&M University System |
Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function
|
WO2012007880A2
(en)
|
2010-07-16 |
2012-01-19 |
Ablynx Nv |
Modified single domain antigen binding molecules and uses thereof
|
EP3578205A1
(de)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
|
US8859723B2
(en)
|
2010-08-13 |
2014-10-14 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
US8916358B2
(en)
|
2010-08-31 |
2014-12-23 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
JP5856621B2
(ja)
|
2010-09-15 |
2016-02-10 |
ゾゲニクス インコーポレーティッド |
無針注射器および注射性能を最適化する同注射器の設計パラメータ
|
WO2012035518A1
(en)
|
2010-09-17 |
2012-03-22 |
Compugen Ltd. |
Compositions and methods for treatment of drug resistant multiple myeloma
|
EP2640405A4
(de)
|
2010-09-21 |
2015-04-15 |
Massachusetts Inst Technology |
An den menschen angepasste ha-polypeptide, impfstoffe daraus und influenza-behandlung damit
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
EP2621514B1
(de)
|
2010-09-28 |
2016-09-21 |
KAHR Medical (2005) Ltd |
Zusammensetzungen und verfahren zur behandlung von hämatologischen malignomen
|
US9228023B2
(en)
|
2010-10-01 |
2016-01-05 |
Oxford Biotherapeutics Ltd. |
Anti-ROR1 antibodies and methods of use for treatment of cancer
|
NZ608630A
(en)
|
2010-10-01 |
2015-03-27 |
Biogen Idec Inc |
Interferon-beta for use as monotherapy or in combination with other cancer therapies
|
US20120237975A1
(en)
|
2010-10-01 |
2012-09-20 |
Jason Schrum |
Engineered nucleic acids and methods of use thereof
|
AU2011312178B2
(en)
|
2010-10-04 |
2016-05-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
CN103154037A
(zh)
|
2010-10-05 |
2013-06-12 |
诺瓦提斯公司 |
抗IL12Rβ1抗体及它们在治疗自身免疫病和炎性疾病中的用途
|
EP2635317B1
(de)
|
2010-11-03 |
2023-03-08 |
Construct Medical Pty Ltd |
Tragbare staubsaugevorrichtung
|
CA2817577A1
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
AU2011333685A1
(en)
|
2010-11-24 |
2013-06-27 |
Glykos Finland Oy |
Fusion enzymes having N-acetylglucosaminyltransferase activity
|
US10208349B2
(en)
|
2011-01-07 |
2019-02-19 |
Ucb Biopharma Sprl |
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
|
GB201100282D0
(en)
|
2011-01-07 |
2011-02-23 |
Ucb Pharma Sa |
Biological methods
|
US8809349B2
(en)
|
2011-01-10 |
2014-08-19 |
Infinity Pharmaceuticals, Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
US9089579B2
(en)
|
2011-01-19 |
2015-07-28 |
Topokine Therapeutics, Inc. |
Methods and compositions for treating metabolic syndrome
|
AU2012209274A1
(en)
|
2011-01-24 |
2013-09-12 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
TR201905477T4
(tr)
|
2011-01-24 |
2019-05-21 |
Anterios Inc |
Nano-parçacık bileşimler.
|
EP2667945A1
(de)
|
2011-01-24 |
2013-12-04 |
Anterios, Inc. |
Ölzusammensetzungen
|
US9084849B2
(en)
|
2011-01-26 |
2015-07-21 |
Kaleo, Inc. |
Medicament delivery devices for administration of a medicament within a prefilled syringe
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US8627816B2
(en)
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
CN103889219A
(zh)
|
2011-03-03 |
2014-06-25 |
特萨斯制药有限责任公司 |
包含C16:1n7-棕榈油酸酯的组合物和方法
|
WO2012119989A2
(en)
|
2011-03-04 |
2012-09-13 |
Oryzon Genomics, S.A. |
Methods and antibodies for the diagnosis and treatment of cancer
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
WO2012135615A2
(en)
|
2011-03-30 |
2012-10-04 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
US20130281932A1
(en)
*
|
2011-03-30 |
2013-10-24 |
Ziv Harish |
Palm-based injector actuation and safety surfaces
|
EP2691101A2
(de)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
WO2012140627A1
(en)
|
2011-04-15 |
2012-10-18 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
|
CN103608065A
(zh)
*
|
2011-04-19 |
2014-02-26 |
因维希德姆有限责任公司 |
含过饱和气体物质的生产方法及其透皮给药设备与使用
|
US20140072622A1
(en)
|
2011-05-17 |
2014-03-13 |
Glaxosmithkline Biologicals S.A. |
Vaccine against streptococcus pneumoniae
|
US8691231B2
(en)
|
2011-06-03 |
2014-04-08 |
Merrimack Pharmaceuticals, Inc. |
Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
|
JP2014519338A
(ja)
|
2011-06-16 |
2014-08-14 |
ノバルティス アーゲー |
治療薬として使用される可溶性タンパク質
|
WO2012177595A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
PE20140756A1
(es)
|
2011-06-28 |
2014-07-04 |
Oxford Biotherapeutics Ltd |
Anticuerpos que se unen a bst1
|
AU2012277376B2
(en)
|
2011-06-30 |
2016-11-24 |
Compugen Ltd. |
Polypeptides and uses thereof for treatment of autoimmune disorders and infection
|
ES2692519T3
(es)
|
2011-07-01 |
2018-12-04 |
Novartis Ag |
Método para tratar trastornos metabólicos
|
AR088218A1
(es)
|
2011-07-19 |
2014-05-21 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos utiles como inhibidores de pi3k
|
AU2012284088B2
(en)
|
2011-07-19 |
2015-10-08 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
CA2842524C
(en)
|
2011-07-22 |
2020-07-14 |
Massachusetts Institute Of Technology |
Activators of class i histone deacetylases (hdacs) and uses thereof
|
EP2736928B1
(de)
|
2011-07-28 |
2019-01-09 |
i2 Pharmaceuticals, Inc. |
Gegen erbb3-gerichtete sur-bindende proteine
|
EP2751093A1
(de)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclische verbindungen und ihre verwendung
|
WO2013030778A2
(en)
|
2011-09-02 |
2013-03-07 |
Novartis Ag |
Organic compositions to treat hsf1-related diseases
|
WO2013036787A2
(en)
|
2011-09-09 |
2013-03-14 |
Greenlight Biosciences, Inc. |
Cell-free preparation of carbapenems
|
CA2848147C
(en)
|
2011-09-09 |
2021-08-24 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
US20130071403A1
(en)
|
2011-09-20 |
2013-03-21 |
Vical Incorporated |
Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
|
MX353958B
(es)
|
2011-09-22 |
2018-02-07 |
Amgen Inc |
Proteinas de union al antigeno cd27l.
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
CA2850624A1
(en)
|
2011-10-03 |
2013-04-11 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
RU2474437C1
(ru)
*
|
2011-10-13 |
2013-02-10 |
Борис Владимирович Смоляров |
Способ осуществления безыгольной инъекции
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
CN108929375A
(zh)
|
2011-10-18 |
2018-12-04 |
爱勒让治疗公司 |
拟肽大环化合物
|
EA026153B1
(ru)
|
2011-11-09 |
2017-03-31 |
Бристол-Майерс Сквибб Компани |
Лечение гематологических злокачественных заболеваний с помощью анти-cxcr4 антитела
|
WO2013074986A1
(en)
|
2011-11-17 |
2013-05-23 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
US8603028B2
(en)
|
2011-11-18 |
2013-12-10 |
Allergan, Inc. |
Injection device having an angled tip portion
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
CN113398126A
(zh)
|
2011-12-16 |
2021-09-17 |
佛罗里达大学研究基金会 |
4′-去铁硫素类似物的用途
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
EP2793940B1
(de)
|
2011-12-22 |
2018-11-14 |
i2 Pharmaceuticals, Inc. |
Surrogatbindungsproteine
|
GB201122305D0
(en)
|
2011-12-23 |
2012-02-01 |
Biotica Tech Ltd |
Novel compound
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
CA2861697C
(en)
|
2012-01-05 |
2022-03-15 |
Novartis Ag |
Protease deficient filamentous fungal cells and methods of use thereof
|
US10023862B2
(en)
|
2012-01-09 |
2018-07-17 |
Arrowhead Pharmaceuticals, Inc. |
Organic compositions to treat beta-catenin-related diseases
|
US10130800B2
(en)
|
2012-01-27 |
2018-11-20 |
Invisiderm, Llc |
Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
|
AU2013216320A1
(en)
|
2012-02-01 |
2014-04-03 |
Compugen Ltd. |
C10RF32 antibodies, and uses thereof for treatment of cancer
|
MX350539B
(es)
|
2012-02-13 |
2017-09-08 |
Bristol Myers Squibb Co |
Compuestos de enediino, conjugados de los mismos y sus usos y metodos.
|
US8927500B2
(en)
|
2012-02-15 |
2015-01-06 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US8987414B2
(en)
|
2012-02-15 |
2015-03-24 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
US20150079100A1
(en)
|
2012-03-23 |
2015-03-19 |
Bristol-Myers Squibb Company |
Methods of treatments using ctla-4 antibodies
|
MX354127B
(es)
|
2012-03-27 |
2018-02-14 |
Amicus Therapeutics Inc |
Compuestos novedosos para prevenir y/o tratar tesaurismosis lisosomicas y/o trastornos degenerativos del sistema nervioso central.
|
WO2013144758A1
(en)
|
2012-03-27 |
2013-10-03 |
Novartis Ag |
Treatment of fibrosis
|
WO2013152279A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
US9273084B2
(en)
|
2012-04-06 |
2016-03-01 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
WO2013151697A1
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
US20130304017A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Bioject, Inc. |
Peformance of needle-free injection according to known relationships
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
MX2014013678A
(es)
|
2012-05-10 |
2015-02-04 |
Massachusetts Inst Technology |
Agentes para neutralizacion de influenza.
|
US9399672B2
(en)
|
2012-05-17 |
2016-07-26 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Hepatitis C virus neutralizing antibody
|
JO3623B1
(ar)
|
2012-05-18 |
2020-08-27 |
Amgen Inc |
البروتينات المرتبطة بمولد المستضاد st2
|
US9522235B2
(en)
|
2012-05-22 |
2016-12-20 |
Kaleo, Inc. |
Devices and methods for delivering medicaments from a multi-chamber container
|
US9695454B2
(en)
|
2012-05-23 |
2017-07-04 |
Glykos Finland Oy |
Production of fucosylated glycoproteins
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
CA2875683A1
(en)
|
2012-06-05 |
2013-12-12 |
The Australian National University |
Vaccination with interleukin-4 antagonists
|
GB201210082D0
(en)
*
|
2012-06-07 |
2012-07-25 |
Consort Medical Plc |
Improved syringe
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
WO2014039983A1
(en)
|
2012-09-07 |
2014-03-13 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
JP2015525794A
(ja)
|
2012-08-06 |
2015-09-07 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乳児においてrsv及び百日咳菌に対する免疫応答を惹起するための方法
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
US10309430B2
(en)
*
|
2012-08-10 |
2019-06-04 |
Confluent Surgical, Inc. |
Pneumatic actuation assembly
|
WO2014028463A1
(en)
|
2012-08-14 |
2014-02-20 |
Allergan, Inc. |
Syringe for mixing and dispensing adipose tissue
|
AU2013306098A1
(en)
|
2012-08-18 |
2015-02-12 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
HUE054444T2
(hu)
|
2012-09-26 |
2021-09-28 |
Harvard College |
Prolinnal lezárt kapcsos peptidek és felhasználásuk
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
JP6321662B2
(ja)
|
2012-10-12 |
2018-05-09 |
ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. |
Gsk3阻害剤およびその使用の方法
|
US10112927B2
(en)
|
2012-10-18 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
US20140114248A1
(en)
|
2012-10-24 |
2014-04-24 |
Nuance Designs, LLC |
Power pack for an autoinjector
|
WO2014065822A1
(en)
|
2012-10-26 |
2014-05-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hepatitis c virus neutralizing epitopes, antibodies, and methods
|
PT2914296T
(pt)
|
2012-11-01 |
2018-10-30 |
Infinity Pharmaceuticals Inc |
Tratamento de cancros utilizando moduladores de isoformas de pi3-quinase
|
JP6526563B2
(ja)
|
2012-11-01 |
2019-06-05 |
エイルロン セラピューティクス,インコーポレイテッド |
二置換アミノ酸ならびにその調製および使用の方法
|
US9567301B2
(en)
|
2012-11-02 |
2017-02-14 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
|
CN104936632B
(zh)
*
|
2012-11-13 |
2017-08-04 |
康斯特鲁科特医疗有限公司 |
便携式抽吸装置
|
CA2869676C
(en)
|
2012-11-21 |
2015-06-23 |
Topokine Therapeutics, Inc. |
Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
ES2780398T3
(es)
|
2012-12-10 |
2020-08-25 |
Biogen Ma Inc |
Anticuerpo anti-antígeno 2 de células dendríticas sanguíneas y uso de los mismos
|
SI2935320T1
(sl)
|
2012-12-18 |
2019-12-31 |
Novartis Ag |
Stabilizirani polipeptidi inzulinu podobnega rastnega faktorja
|
WO2014100716A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
US8906900B2
(en)
|
2012-12-21 |
2014-12-09 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
US8940726B2
(en)
|
2012-12-21 |
2015-01-27 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
JP6678455B2
(ja)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
WO2014106056A2
(en)
|
2012-12-27 |
2014-07-03 |
Kaleo, Inc. |
Devices, systems and methods for locating and interacting with medicament delivery systems
|
CA2897941A1
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
ES2728936T3
(es)
|
2013-01-25 |
2019-10-29 |
Amgen Inc |
Anticuerpos dirigidos contra CDH19 para melanoma
|
WO2014124228A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
JP6518597B2
(ja)
|
2013-02-07 |
2019-05-22 |
マサチューセッツ インスティテュート オブ テクノロジー |
H5インフルエンザのヒトへの適応
|
SI2953969T1
(sl)
|
2013-02-08 |
2020-01-31 |
Novartis Ag |
Protitelesa proti-IL-17A in njihova uporaba v zdravljenju avtoimunskih in vnetnih motenj
|
RS56169B1
(sr)
|
2013-02-14 |
2017-11-30 |
Bristol Myers Squibb Co |
Jedinjenja tubulisina, metode pripreme i primena
|
CA2902068C
(en)
|
2013-02-28 |
2023-10-03 |
Caprion Proteomics Inc. |
Tuberculosis biomarkers and uses thereof
|
KR20150131244A
(ko)
|
2013-03-13 |
2015-11-24 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스테이플드 및 스티치드 폴리펩티드 및 그의 용도
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
SG11201504260UA
(en)
|
2013-03-14 |
2015-10-29 |
Abbvie Inc |
Low acidic species compositions and methods for producing and using the same
|
WO2014159554A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
Low acidic species compositions and methods for producing the same using displacement chromatography
|
US9580486B2
(en)
|
2013-03-14 |
2017-02-28 |
Amgen Inc. |
Interleukin-2 muteins for the expansion of T-regulatory cells
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
CA2903546A1
(en)
|
2013-03-15 |
2014-09-25 |
Biogen Ma Inc. |
Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
|
WO2014144466A1
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Anti-alpha v beta 6 antibodies and uses thereof
|
US9505849B2
(en)
|
2013-03-15 |
2016-11-29 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza M2 and CD3
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
WO2014143739A2
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Anti-alpha v beta 6 antibodies and uses thereof
|
AR095596A1
(es)
|
2013-03-15 |
2015-10-28 |
Amgen Res (Munich) Gmbh |
Moléculas de unión de cadena única comprendiendo n-terminal abp
|
AU2014248090B2
(en)
|
2013-04-03 |
2018-08-02 |
N-Fold Llc |
Novel nanoparticle compositions
|
CN111825733A
(zh)
|
2013-04-04 |
2020-10-27 |
哈佛大学的校长及成员们 |
大环内酯及其制备和使用方法
|
ES2774330T3
(es)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Polímero de suministro de fármaco y usos del mismo
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(de)
|
2013-05-10 |
2018-06-16 |
|
|
WO2014186504A1
(en)
|
2013-05-15 |
2014-11-20 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
US20140350518A1
(en)
|
2013-05-23 |
2014-11-27 |
Allergan, Inc. |
Syringe extrusion accessory
|
US20140350516A1
(en)
|
2013-05-23 |
2014-11-27 |
Allergan, Inc. |
Mechanical syringe accessory
|
EA201592285A1
(ru)
|
2013-05-30 |
2016-05-31 |
Байоджен Ма Инк. |
Антигенсвязывающие белки к рецептору онкостатина м
|
DK3003309T3
(da)
|
2013-05-30 |
2020-12-14 |
Infinity Pharmaceuticals Inc |
Behandling af cancer med PI3-kinase-isoform modulatorer
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
EP3030239A4
(de)
|
2013-06-11 |
2017-03-08 |
Kala Pharmaceuticals, Inc. |
Harnstoffderivate und verwendungen davon
|
CN105492460A
(zh)
|
2013-06-14 |
2016-04-13 |
哈佛大学的校长及成员们 |
稳定化多肽胰岛素受体调控剂
|
EP3013818B1
(de)
|
2013-06-26 |
2021-12-29 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
(s)-enantiomer von mepazin als paracaspase (malt1) inhibitor zur behandlung von krebs
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
EP3013347B1
(de)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glykankonjugate und verwendung davon
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
CA2919773A1
(en)
|
2013-08-05 |
2015-02-12 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
BR112016002494A2
(pt)
|
2013-08-05 |
2017-09-05 |
Greenlight Biosciences Inc |
Proteí-nas construídas com um sítio de clivagem de protease, ácido nucléico, vetor, célula e processo de engenharia de uma proteína recombinante e de um grande número de variantes de ácidos nucleicos que codificam proteínas recombinantes
|
TWI532511B
(zh)
*
|
2013-08-16 |
2016-05-11 |
京華堂實業股份有限公司 |
無針型注射系統及其注射方法
|
CN105682666B
(zh)
|
2013-09-06 |
2021-06-01 |
中央研究院 |
使用醣脂激活人类iNKT细胞
|
AR097648A1
(es)
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
CN105792839A
(zh)
|
2013-10-02 |
2016-07-20 |
诺华股份有限公司 |
用于治疗的胰岛素样生长因子拟似物
|
WO2015051234A2
(en)
|
2013-10-04 |
2015-04-09 |
Biogen Idec Ma Inc. |
Tweak antagonists for treating lupus nephritis and muscle atrophy
|
PE20160685A1
(es)
|
2013-10-04 |
2016-07-23 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
PT3055331T
(pt)
|
2013-10-11 |
2021-04-05 |
Oxford Bio Therapeutics Ltd |
Anticorpos conjugados contra ly75 para o tratamento de cancro
|
US9982009B2
(en)
|
2013-10-15 |
2018-05-29 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
WO2015057958A2
(en)
|
2013-10-16 |
2015-04-23 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
ES2676734T3
(es)
|
2013-10-18 |
2018-07-24 |
Syros Pharmaceuticals, Inc. |
Compuestos heteroatómicos útiles para el tratamiento de enfermedades proliferativas
|
JP6491202B2
(ja)
|
2013-10-18 |
2019-03-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
サイクリン依存性キナーゼ7(cdk7)の多環阻害剤
|
WO2015057939A1
(en)
|
2013-10-18 |
2015-04-23 |
Biogen Idec Ma Inc. |
Anti-s1p4 antibodies and uses thereof
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP6426194B2
(ja)
|
2013-11-01 |
2018-11-21 |
カラ ファーマシューティカルズ インコーポレイテッド |
治療用化合物の結晶形態及びその使用
|
UY35874A
(es)
|
2013-12-12 |
2015-07-31 |
Novartis Ag |
Un proceso para la preparación de una composición de proteínas pegiladas
|
CN113402609B
(zh)
|
2013-12-20 |
2023-12-05 |
英特维特国际股份有限公司 |
具有经修饰的ch2-ch3序列的犬抗体
|
TWI728373B
(zh)
|
2013-12-23 |
2021-05-21 |
美商建南德克公司 |
抗體及使用方法
|
PL3712174T3
(pl)
|
2013-12-24 |
2022-07-04 |
Janssen Pharmaceutica Nv |
Przeciwciała i fragmenty anty-vista
|
EA201891279A1
(ru)
|
2013-12-24 |
2019-01-31 |
Президент Энд Феллоус Оф Гарвард Колледж |
Аналоги кортистатина, их синтез и применения
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
US9982041B2
(en)
|
2014-01-16 |
2018-05-29 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP2017504651A
(ja)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
ジアゼパン誘導体の使用
|
WO2015123385A1
(en)
|
2014-02-12 |
2015-08-20 |
Amicus Therapeutics, Inc. |
Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of mps iiic
|
JP6625071B2
(ja)
|
2014-03-07 |
2019-12-25 |
ザ アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
慢性疼痛用のナトリウムチャネルを標的とする非麻薬性crmp2ペプチド
|
SG10201808053XA
(en)
|
2014-03-19 |
2018-10-30 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
TWI687428B
(zh)
|
2014-03-27 |
2020-03-11 |
中央研究院 |
反應性標記化合物及其用途
|
ES2868305T3
(es)
|
2014-03-28 |
2021-10-21 |
Univ Washington Through Its Center For Commercialization |
Vacunas contra el cáncer de mama y de ovario
|
US9675627B2
(en)
|
2014-04-14 |
2017-06-13 |
Amicus Therapeutics, Inc. |
Dosing regimens for treating and/or preventing cerebral amyloidoses
|
US10017477B2
(en)
|
2014-04-23 |
2018-07-10 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
WO2015168380A1
(en)
|
2014-04-30 |
2015-11-05 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
US10029048B2
(en)
|
2014-05-13 |
2018-07-24 |
Allergan, Inc. |
High force injection devices
|
CN106573032B
(zh)
|
2014-05-21 |
2022-03-18 |
哈佛大学的校长及成员们 |
Ras抑制肽和其用途
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
CN106573971A
(zh)
|
2014-05-27 |
2017-04-19 |
中央研究院 |
抗cd20醣抗体及其用途
|
EP3149161B1
(de)
|
2014-05-27 |
2021-07-28 |
Academia Sinica |
Fucosidase aus bacteroiden und verfahren damit
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
TWI732738B
(zh)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
抗TNF-α醣抗體及其用途
|
JP6612017B2
(ja)
*
|
2014-06-03 |
2019-11-27 |
株式会社ダイセル |
無針注射器による注射システム
|
EA037006B1
(ru)
|
2014-06-06 |
2021-01-26 |
Бристол-Майерс Сквибб Компани |
Антитела к индуцируемому глюкокортикоидами рецептору фактора некроза опухолей (gitr) и их применения
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
EP3154576A1
(de)
|
2014-06-13 |
2017-04-19 |
GlaxoSmithKline Biologicals S.A. |
Immunogene kombinationen
|
SI3157916T1
(sl)
|
2014-06-19 |
2019-05-31 |
Ariad Pharmaceuticals, Inc. |
Heteroarilne spojine za zaviranja kinaze
|
EP2959931A1
(de)
|
2014-06-24 |
2015-12-30 |
LTS LOHMANN Therapie-Systeme AG |
Nadellose Injektionsvorrichtung
|
EP3161001A2
(de)
|
2014-06-25 |
2017-05-03 |
Novartis AG |
Il17-a spezifische antikörper die mit hyaluronan bindenden peptid-marker fusioniert sind
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
WO2016004197A1
(en)
|
2014-07-03 |
2016-01-07 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
|
US20160185848A1
(en)
|
2014-07-09 |
2016-06-30 |
Abbvie Inc. |
Methods for modulating the glycosylation profile of recombinant proteins using sugars
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
EP3169699A4
(de)
|
2014-07-18 |
2018-06-20 |
The University of Washington |
Krebsimpfstoffzusammensetzungen und verfahren zur verwendung davon
|
WO2016016415A1
(en)
|
2014-07-31 |
2016-02-04 |
Amgen Research (Munich) Gmbh |
Bispecific single chain antibody construct with enhanced tissue distribution
|
AR101669A1
(es)
|
2014-07-31 |
2017-01-04 |
Amgen Res (Munich) Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
JP6749312B2
(ja)
|
2014-07-31 |
2020-09-02 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
最適化された種間特異的二重特異性単鎖抗体コンストラクト
|
EP2979714A1
(de)
|
2014-08-02 |
2016-02-03 |
LTS LOHMANN Therapie-Systeme AG |
Nadellose Injektionsvorrichtung aufweisend eine Membran
|
WO2016025331A1
(en)
|
2014-08-11 |
2016-02-18 |
University Of Massachusetts |
Anti-ospa antibodies and methods of use
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
IL250583B
(en)
|
2014-08-19 |
2022-07-01 |
Merck Sharp & Dohme |
Anti-tigit antibodies
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
WO2016040369A2
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
|
EP2993174A1
(de)
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridinderivate und deren Verwendung in der Therapie
|
SG10201902594QA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
US10905739B2
(en)
|
2014-09-24 |
2021-02-02 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
US10226585B2
(en)
|
2014-10-01 |
2019-03-12 |
Allergan, Inc. |
Devices for injection and dosing
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
AU2015327819B2
(en)
|
2014-10-03 |
2021-07-01 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
TN2017000157A1
(en)
|
2014-10-21 |
2018-10-19 |
Ariad Pharma Inc |
Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine
|
EP3011988A1
(de)
|
2014-10-22 |
2016-04-27 |
LTS LOHMANN Therapie-Systeme AG |
Nadellose Injektionsvorrichtung aufweisend ein Gel und eine Membran
|
US20180015101A1
(en)
|
2014-10-28 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
EP3461904A1
(de)
|
2014-11-10 |
2019-04-03 |
ModernaTX, Inc. |
Alternative nukleinsäuremoleküle mit reduziertem uracilgehalt und verwendungen davon
|
US10647687B2
(en)
|
2014-11-10 |
2020-05-12 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) |
Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
RS60631B1
(sr)
|
2014-11-21 |
2020-09-30 |
Bristol Myers Squibb Co |
Antitela protiv cd73 i njihova upotreba
|
EP3221346B1
(de)
|
2014-11-21 |
2020-09-02 |
Bristol-Myers Squibb Company |
Antikörper mit modifizierten schweren konstanten regionen
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
EP3227341A1
(de)
|
2014-12-02 |
2017-10-11 |
CeMM - Forschungszentrum für Molekulare Medizin GmbH |
Anti-mutante calreticulin-antikörper und deren verwendung bei der diagnose und therapie von myeloiden malignomen
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
EP3230272B1
(de)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazol(1,5-a)pyridin-substituiertes harnstoffderivat und verwendungen davon
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
PT3233912T
(pt)
|
2014-12-19 |
2021-08-09 |
Regenesance B V |
Antocorpos que se ligam a c6 humano e utilizações destes
|
WO2016105528A2
(en)
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
AU2015369707B2
(en)
|
2014-12-23 |
2020-07-23 |
Sloan-Kettering Institute For Cancer Research |
Polymorph of granaticin B
|
TWI708786B
(zh)
|
2014-12-23 |
2020-11-01 |
美商必治妥美雅史谷比公司 |
針對tigit之抗體
|
AU2016206191B2
(en)
|
2015-01-09 |
2017-08-03 |
Adalta Limited |
CXCR4 binding molecules
|
WO2016115201A1
(en)
|
2015-01-14 |
2016-07-21 |
Bristol-Myers Squibb Company |
Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3248005B1
(de)
|
2015-01-24 |
2020-12-09 |
Academia Sinica |
Neuartige glycankonjugate und verfahren zur verwendung davon
|
US20160222060A1
(en)
|
2015-02-04 |
2016-08-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2016127052A1
(en)
|
2015-02-05 |
2016-08-11 |
Bristol-Myers Squibb Company |
Cxcl11 and smica as predictive biomarkers for efficacy of anti-ctla4 immunotherapy
|
WO2016144773A1
(en)
|
2015-03-06 |
2016-09-15 |
Abbvie Inc. |
Arabinosylated glycoproteins
|
EP3268037B1
(de)
|
2015-03-09 |
2022-08-31 |
Celldex Therapeutics, Inc. |
Cd27 agonists
|
BR112017019272A2
(pt)
|
2015-03-10 |
2018-05-02 |
Allergan Pharmaceuticals Holdings Ireland Unlimited Company |
injetor de múltiplas agulhas
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
MX2017011834A
(es)
|
2015-03-20 |
2018-04-11 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos y usos de los mismos.
|
WO2016154010A1
(en)
|
2015-03-20 |
2016-09-29 |
Makidon Paul |
Immunogenic compositions for use in vaccination against bordetella
|
AU2016235054B2
(en)
|
2015-03-24 |
2020-07-16 |
Kaleo, Inc. |
Devices and methods for delivering a lyophilized medicament
|
CA2978518C
(en)
|
2015-03-27 |
2023-11-21 |
Nathanael S. Gray |
Inhibitors of cyclin-dependent kinases
|
MX2017012665A
(es)
|
2015-03-30 |
2018-04-24 |
Greenlight Biosciences Inc |
Produccion de acido ribonucleico libre de celulas.
|
DK3277722T3
(da)
|
2015-04-02 |
2021-10-11 |
Intervet Int Bv |
Antistoffer mod canin interleukin-4 receptor alpha
|
MX2017012966A
(es)
|
2015-04-10 |
2018-06-06 |
Amgen Inc |
Muteinas de interleuquina 2 para la expansion de celulas t regulatorias.
|
WO2016162405A1
(en)
|
2015-04-10 |
2016-10-13 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Pyrone derivatives for use as antiviral agents
|
EP4276116A3
(de)
|
2015-04-17 |
2024-01-17 |
Amgen Research (Munich) GmbH |
Bispezifische antikörperkonstrukte für cdh3 und cd3
|
US10570104B2
(en)
|
2015-04-27 |
2020-02-25 |
University Of Florida Research Foundation, Incorporated |
Metabolically programmed metal chelators and uses thereof
|
TW201702271A
(zh)
|
2015-04-30 |
2017-01-16 |
哈佛大學校長及研究員協會 |
治療代謝病症之抗-ap2抗體及抗原結合劑
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
WO2016187068A1
(en)
|
2015-05-15 |
2016-11-24 |
The General Hospital Corporation |
Antagonistic anti-tumor necrosis factor receptor superfamily antibodies
|
US10568852B2
(en)
|
2015-05-22 |
2020-02-25 |
Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) |
Combination compositions and their use in methods for treating obesity and obesity-related disorders
|
EA039951B1
(ru)
|
2015-05-27 |
2022-03-31 |
Юсб Биофарма Спрл |
Ингибитор активности csf-1r, предназначенный для лечения или профилактики эпилепсии или болезни паркинсона, и фармацевтическая композиция на его основе
|
US11078259B2
(en)
*
|
2015-06-05 |
2021-08-03 |
Joslin Diabetes Center, Inc. |
Methods and compositions for promoting thermogenic potential
|
EP3307728A4
(de)
|
2015-06-12 |
2019-07-17 |
Dana Farber Cancer Institute, Inc. |
Kombinationstherapie von transkriptionshemmern und kinasehemmern
|
EP3307348A2
(de)
*
|
2015-06-15 |
2018-04-18 |
Nuance Designs of CT, LLC |
Gasbetriebener autoinjektor mit gasdurchflussregler
|
JP2017000667A
(ja)
|
2015-06-16 |
2017-01-05 |
国立大学法人三重大学 |
無針注射器及びそれを用いた注射対象領域へのdna導入方法
|
US10201618B2
(en)
|
2015-06-19 |
2019-02-12 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
AU2016285920A1
(en)
|
2015-06-29 |
2018-02-01 |
Bristol-Myers Squibb Company |
Antibodies to CD40 with enhanced agonist activity
|
JP6830067B2
(ja)
|
2015-06-30 |
2021-02-17 |
カレオ,インコーポレイテッド |
プレフィルドシリンジ内の医薬を投与する自動注射器
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
CA2991980A1
(en)
|
2015-07-13 |
2017-01-19 |
Compugen Ltd. |
Hide1 compositions and methods
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI793062B
(zh)
|
2015-07-31 |
2023-02-21 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
JO3620B1
(ar)
|
2015-08-05 |
2020-08-27 |
Amgen Res Munich Gmbh |
مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم
|
US10179128B2
(en)
|
2015-08-31 |
2019-01-15 |
Amicus Therapeutics, Inc. |
Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
|
EP4019515A1
(de)
|
2015-09-09 |
2022-06-29 |
Dana-Farber Cancer Institute, Inc. |
Hemmer von cyclinabhängigen kinasen
|
EP3347372A4
(de)
|
2015-09-10 |
2019-09-04 |
Aileron Therapeutics, Inc. |
Peptidomimetische makrocyclen als modulatoren von mcl-1
|
AU2016324310B2
(en)
|
2015-09-17 |
2021-04-08 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
US20180256750A1
(en)
|
2015-09-17 |
2018-09-13 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a stabilizing tail region
|
RU2638457C2
(ru)
|
2015-09-28 |
2017-12-13 |
Общество С Ограниченной Ответственностью "Онкомакс" |
Антитела, специфически связывающие рецептор 1 типа фактора роста фибробластов, применение антител для лечения онкологического заболевания, способ получения антител
|
WO2017059132A1
(en)
|
2015-09-29 |
2017-04-06 |
The General Hospital Corporation |
Methods of treating and diagnosing disease using biomarkers for bcg therapy
|
AU2016330772A1
(en)
|
2015-09-30 |
2018-04-19 |
Rhythm Pharmaceuticals, Inc. |
Method of treating melanocortin-4 receptor pathway-associated disorders
|
WO2017059389A1
(en)
|
2015-10-01 |
2017-04-06 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JO3555B1
(ar)
|
2015-10-29 |
2020-07-05 |
Merck Sharp & Dohme |
جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
|
JP6998869B2
(ja)
|
2015-11-08 |
2022-02-04 |
ジェネンテック, インコーポレイテッド |
多重特異性抗体のスクリーニング方法
|
US10513553B2
(en)
|
2015-11-13 |
2019-12-24 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
AU2016356780A1
(en)
|
2015-11-19 |
2018-06-28 |
Bristol-Myers Squibb Company |
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
|
AR108824A1
(es)
|
2015-11-21 |
2018-10-03 |
Fundacio Privada Inst De Recerca De La Sida Caixa Irsicaixa |
Derivados de anticuerpos contra el vih con actividad dual antiviral e inmunomodulatoria
|
WO2017095875A1
(en)
|
2015-11-30 |
2017-06-08 |
Bristol-Myers Squibb Company |
Anti human ip-10 antibodies and their uses
|
CA3006759A1
(en)
|
2015-11-30 |
2017-06-08 |
The Regents Of The University Of California |
Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
|
US10596248B2
(en)
|
2015-12-09 |
2020-03-24 |
Jingang Medicine (Australia) Pty Ltd |
Immunomodulating composition for treatment
|
PL3394030T3
(pl)
|
2015-12-22 |
2022-04-11 |
Modernatx, Inc. |
Związki i kompozycje do wewnątrzkomórkowego dostarczania środków
|
CN108884169B
(zh)
|
2016-01-22 |
2022-03-22 |
默沙东公司 |
抗凝血因子xi抗体
|
JOP20170017B1
(ar)
|
2016-01-25 |
2021-08-17 |
Amgen Res Munich Gmbh |
تركيب صيدلي يتضمن تركيبات جسم مضاد ثنائي الاختصاص
|
EP3411404B1
(de)
|
2016-02-03 |
2022-11-09 |
Amgen Research (Munich) GmbH |
Psma- und cd3-bispezifische t-zellaktivierende antikörperkonstrukte
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
KR20180103084A
(ko)
|
2016-02-03 |
2018-09-18 |
암젠 리서치 (뮌헨) 게엠베하 |
Bcma 및 cd3 이중특이성 t 세포 맞물림 항체 작제물
|
CN116920085A
(zh)
|
2016-02-12 |
2023-10-24 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
RU2018131123A
(ru)
|
2016-02-17 |
2020-03-17 |
Новартис Аг |
Антитела к tgf-бета2
|
JP7104629B2
(ja)
|
2016-02-24 |
2022-07-21 |
ビステラ, インコーポレイテッド |
インフルエンザウイルスに対する抗体分子の製剤
|
US10143746B2
(en)
|
2016-03-04 |
2018-12-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
SG11201807677YA
(en)
|
2016-03-04 |
2018-10-30 |
Univ Rockefeller |
Antibodies to cd40 with enhanced agonist activity
|
EA201891983A8
(ru)
|
2016-03-04 |
2020-05-28 |
Бристол-Майерс Сквибб Компани |
Комбинированная терапия антителами к cd73
|
TW201808978A
(zh)
|
2016-03-08 |
2018-03-16 |
中央研究院 |
N-聚醣及其陣列之模組化合成方法
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
KR102535764B1
(ko)
|
2016-03-28 |
2023-05-30 |
아이커 메디칼 시스템스 인코포레이티드 |
치료제를 전달하기 위한 장치
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
EP4293104A3
(de)
|
2016-04-06 |
2024-04-24 |
Greenlight Biosciences, Inc. |
Zellfreie herstellung von ribonukleinsäure
|
CA3020146A1
(en)
|
2016-04-08 |
2017-10-12 |
Allergan, Inc. |
Aspiration and injection device
|
RU2021111187A
(ru)
|
2016-04-15 |
2021-04-29 |
Янссен Фармасьютикалз, Инк. |
Антитела против человеческого vista и их применение
|
WO2017184586A1
(en)
|
2016-04-18 |
2017-10-26 |
The Trustees Of Columbia University In The City Of New York |
Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (nash)
|
MA44723A
(fr)
|
2016-04-18 |
2019-02-27 |
Celldex Therapeutics Inc |
Anticorps agonistes se liant au cd40 humain et leurs utilisations
|
JOP20170091B1
(ar)
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|
SI3445850T1
(sl)
|
2016-04-22 |
2021-12-31 |
BioNTech SE |
Postopki za zagotavljanje enoverižne RNA
|
ES2886966T3
(es)
*
|
2016-04-29 |
2021-12-21 |
Altaviz Llc |
Jeringa autoalimentada
|
KR20180133198A
(ko)
|
2016-05-04 |
2018-12-13 |
암젠 인크 |
T-조절 세포의 증식을 위한 인터류킨-2 뮤테인
|
EP3455256A1
(de)
|
2016-05-09 |
2019-03-20 |
Bristol-Myers Squibb Company |
Tl1a-antikörper und verwendungen davon
|
TW201802121A
(zh)
|
2016-05-25 |
2018-01-16 |
諾華公司 |
抗因子XI/XIa抗體之逆轉結合劑及其用途
|
SG10201913650WA
(en)
|
2016-06-03 |
2020-03-30 |
Sanofi Pasteur Inc |
Modification of engineered influenza hemagglutinin polypeptides
|
US10105449B2
(en)
|
2016-06-07 |
2018-10-23 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
AU2017286606A1
(en)
|
2016-06-14 |
2018-12-13 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
AU2017286432B2
(en)
|
2016-06-14 |
2020-09-24 |
Adimab, Llc |
Anti-coagulation factor XI antibodies
|
US20180002417A1
(en)
|
2016-06-15 |
2018-01-04 |
Celimmune Llc |
Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
US10328205B2
(en)
*
|
2016-07-07 |
2019-06-25 |
Shl Medical Ag |
Drug delivery device with pneumatic power pack
|
JP7027401B2
(ja)
|
2016-07-14 |
2022-03-01 |
ブリストル-マイヤーズ スクイブ カンパニー |
Tim3に対する抗体およびその使用
|
WO2018018082A1
(en)
|
2016-07-26 |
2018-02-01 |
The Australian National University |
Immunostimulatory compositions and uses therefor
|
US20180028755A1
(en)
*
|
2016-07-28 |
2018-02-01 |
Portal Instruments, Inc. |
Connected health platform including needle-free injector system
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
WO2018027042A1
(en)
|
2016-08-03 |
2018-02-08 |
Bio-Techne Corporation |
Identification of vsig3/vista as a novel immune checkpoint and use thereof for immunotherapy
|
CN109862908B
(zh)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
MX2019001341A
(es)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Composicion de conjugado de polisacarido neumococico multivalente-proteina.
|
NL2017294B1
(en)
|
2016-08-05 |
2018-02-14 |
Univ Erasmus Med Ct Rotterdam |
Natural cryptic exon removal by pairs of antisense oligonucleotides.
|
KR102493853B1
(ko)
|
2016-08-19 |
2023-01-30 |
브리스톨-마이어스 스큅 컴퍼니 |
세코-시클로프로파피롤로인돌 화합물, 그의 항체-약물 접합체, 및 제조 및 사용 방법
|
JP7213549B2
(ja)
|
2016-08-22 |
2023-01-27 |
シーエイチオー ファーマ インコーポレイテッド |
抗体、結合性断片、および使用の方法
|
WO2018035710A1
(en)
|
2016-08-23 |
2018-03-01 |
Akeso Biopharma, Inc. |
Anti-ctla4 antibodies
|
WO2018044970A1
(en)
|
2016-08-31 |
2018-03-08 |
University Of Rochester |
Human monoclonal antibodies to human endogenous retrovirus k envelope (herv-k) and uses thereof
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
EP3305781A1
(de)
|
2016-10-07 |
2018-04-11 |
Deutsches Krebsforschungszentrum |
Chemische substanzen welche die enzymatische aktivität der humanen kallikrein-related peptidase 6 (klk6) hemmen.
|
WO2018071822A2
(en)
|
2016-10-13 |
2018-04-19 |
Massachusetts Institute Of Technology |
Antibodies that bind zika virus envelope protein and uses thereof
|
WO2018081578A1
(en)
|
2016-10-28 |
2018-05-03 |
Astute Medical, Inc. |
Use of antibodies to timp-2 for the improvement of renal function
|
CN110267971B
(zh)
|
2016-11-07 |
2023-12-19 |
百时美施贵宝公司 |
免疫调节剂
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
US11434301B2
(en)
|
2016-11-11 |
2022-09-06 |
The Regents Of The University Of California |
Anti-CD46 antibodies and methods of use
|
CN110062626A
(zh)
|
2016-11-18 |
2019-07-26 |
纽维制药有限公司 |
sanglifehrin大环类似物作为抗癌化合物的用途
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
KR20190096409A
(ko)
|
2016-12-21 |
2019-08-19 |
메레오 바이오파마 3 리미티드 |
불완전 골형성증 치료에서의 항-스클레로스틴 항체의 용도
|
WO2018115879A1
(en)
|
2016-12-21 |
2018-06-28 |
Mereo Biopharma 3 Limited |
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
|
EP3559047A1
(de)
|
2016-12-23 |
2019-10-30 |
Novartis AG |
Faktor xi-antikörper und verfahren zur verwendung
|
AU2017379094B2
(en)
|
2016-12-23 |
2023-08-24 |
Kaleo, Inc. |
Medicament delivery device and methods for delivering drugs to infants and children
|
KR20240031326A
(ko)
|
2016-12-31 |
2024-03-07 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
불안의 치료를 위한 설하 덱스메데토미딘의 용도
|
US11702458B2
(en)
|
2017-01-05 |
2023-07-18 |
Kahr Medical Ltd. |
PD1-41BBL fusion protein and methods of use thereof
|
SI3565828T1
(sl)
|
2017-01-05 |
2022-04-29 |
Kahr Medical Ltd. |
SIRP1 alfa-41BBL fuzijski protein in postopki za njegovo uporabo
|
US20180244785A1
(en)
|
2017-01-09 |
2018-08-30 |
Merrimack Pharmaceuticals, Inc. |
Anti-fgfr antibodies and methods of use
|
US10332623B2
(en)
|
2017-01-17 |
2019-06-25 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and event detection
|
US11377497B2
(en)
|
2017-01-23 |
2022-07-05 |
Suzhou Alphamab Co., Ltd. |
PD-L1 binding polypeptide or composite
|
WO2018140510A1
(en)
|
2017-01-25 |
2018-08-02 |
Biogen Ma Inc. |
Compositions and methods for treatment of stroke and other cns disorders
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
GB2559553B
(en)
*
|
2017-02-06 |
2021-10-13 |
Consort Medical Plc |
A medicament delivery device
|
GB201702144D0
(en)
|
2017-02-09 |
2017-03-29 |
Annexin Pharmaceuticals Ab |
Therapeutic compositions
|
CN110603038A
(zh)
|
2017-02-10 |
2019-12-20 |
塔姆山治疗公司 |
雷帕霉素类似物
|
EP3583124A1
(de)
|
2017-02-17 |
2019-12-25 |
Bristol-Myers Squibb Company |
Antikörper gegen alpha-synuklein und verwendungen davon
|
GB201703876D0
(en)
|
2017-03-10 |
2017-04-26 |
Berlin-Chemie Ag |
Pharmaceutical combinations
|
HUE060693T2
(hu)
|
2017-03-15 |
2023-04-28 |
Modernatx Inc |
Vegyület és készítmények terápiás szerek intracelluláris bejuttatására
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
USD867582S1
(en)
|
2017-03-24 |
2019-11-19 |
Allergan, Inc. |
Syringe device
|
JP7157075B2
(ja)
|
2017-04-05 |
2022-10-19 |
ザ ブロード インスティテュート,インコーポレーテッド |
グリコーゲンシンターゼキナーゼ3(gsk3)インヒビターとしての三環式化合物およびそれらの使用
|
TWI796329B
(zh)
|
2017-04-07 |
2023-03-21 |
美商默沙東有限責任公司 |
抗-ilt4抗體及抗原結合片段
|
TWI788340B
(zh)
|
2017-04-07 |
2023-01-01 |
美商必治妥美雅史谷比公司 |
抗icos促效劑抗體及其用途
|
AU2018252546A1
(en)
|
2017-04-13 |
2019-10-10 |
Sairopa B.V. |
Anti-SIRPα antibodies
|
KR20190134807A
(ko)
|
2017-04-25 |
2019-12-04 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
중추 신경계의 퇴행성 질환 및/또는 리소솜 저장병을 예방 및/또는 치료하기 위한 신규한 조성물
|
WO2018204907A1
(en)
|
2017-05-05 |
2018-11-08 |
Amgen Inc. |
Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration
|
AU2018266847A1
(en)
|
2017-05-10 |
2019-11-28 |
Albajuna Therapeutics, S.L. |
Fc-fusion protein derivatives with high dual HIV antiviral and immunomodulatory activity
|
CN111094335B
(zh)
|
2017-05-15 |
2022-08-23 |
罗切斯特大学 |
广泛中和的抗流感单克隆抗体及其用途
|
KR20220167342A
(ko)
|
2017-05-25 |
2022-12-20 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 중쇄 불변 영역을 포함하는 항체
|
US20210198200A1
(en)
|
2017-06-14 |
2021-07-01 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
WO2018233333A1
(zh)
|
2017-06-23 |
2018-12-27 |
苏州博聚华生物医药科技有限公司 |
一种靶向人肿瘤干细胞的单克隆抗体及其应用
|
KR20200020858A
(ko)
|
2017-06-23 |
2020-02-26 |
브리스톨-마이어스 스큅 컴퍼니 |
Pd-1의 길항제로서 작용하는 면역조정제
|
US11612647B2
(en)
|
2017-06-23 |
2023-03-28 |
University Of Maryland, Baltimore |
Immunogenic compositions
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
MX2020001851A
(es)
|
2017-08-22 |
2020-08-20 |
Biogen Ma Inc |
Composiciones farmaceuticas y regimenes de dosificacion que contienen anticuerpos anti-alfa(v)beta(6).
|
MX2020002351A
(es)
|
2017-08-28 |
2021-02-26 |
Shanghai Yile Biotechnology Co Ltd |
Polipeptido y anticuerpo unido al polipeptido.
|
US11414450B1
(en)
|
2017-08-28 |
2022-08-16 |
Revagenix, Inc. |
Aminoglycosides and uses thereof
|
JP7275111B2
(ja)
|
2017-08-31 |
2023-05-17 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の生成方法
|
US11492375B2
(en)
|
2017-10-03 |
2022-11-08 |
Bristol-Myers Squibb Company |
Cyclic peptide immunomodulators
|
SG11202003114UA
(en)
|
2017-10-04 |
2020-05-28 |
Amgen Inc |
Transthyretin immunoglobulin fusions
|
WO2019075090A1
(en)
|
2017-10-10 |
2019-04-18 |
Tilos Therapeutics, Inc. |
ANTI-LAP ANTIBODIES AND USES THEREOF
|
AU2018347405B2
(en)
|
2017-10-11 |
2022-02-03 |
Greenlight Biosciences, Inc. |
Methods and compositions for nucleoside triphosphate and ribonucleic acid production
|
EP3700938A1
(de)
|
2017-10-26 |
2020-09-02 |
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. |
Neuartige rekombinante fusionsproteine, herstellung und verwendung davon
|
WO2019089921A1
(en)
|
2017-11-01 |
2019-05-09 |
Bristol-Myers Squibb Company |
Immunostimulatory agonistic antibodies for use in treating cancer
|
KR102478433B1
(ko)
|
2017-11-17 |
2022-12-15 |
머크 샤프 앤드 돔 엘엘씨 |
이뮤노글로불린-유사 전사체 3 (ilt3)에 대해 특이적인 항체 및 그의 용도
|
US11786477B2
(en)
|
2017-12-01 |
2023-10-17 |
North Carolina State University |
Fibrin particles and methods of making the same
|
EP3724229A1
(de)
|
2017-12-11 |
2020-10-21 |
Amgen Inc. |
Kontinuierliches herstellungsverfahren für bispezifische antikörperprodukte
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
SG11202004966PA
(en)
|
2017-12-21 |
2020-06-29 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising a dementia
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
CN111432801A
(zh)
*
|
2017-12-21 |
2020-07-17 |
台湾微脂体股份有限公司 |
缓释型曲普坦组合物及通过皮下或类似途径使用其的方法
|
SG11202004971YA
(en)
|
2017-12-21 |
2020-06-29 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
|
EP3732198A1
(de)
|
2017-12-27 |
2020-11-04 |
Bristol-Myers Squibb Company |
Anti-cd40-antikörper und verwendungen davon
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
JP7358361B2
(ja)
|
2018-01-12 |
2023-10-10 |
ブリストル-マイヤーズ スクイブ カンパニー |
Tim3に対する抗体およびその使用
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
CN111868082A
(zh)
|
2018-02-02 |
2020-10-30 |
博奥泰克尼公司 |
调节vista和vsig3的相互作用的化合物及其制备和使用方法
|
KR101859735B1
(ko)
*
|
2018-02-07 |
2018-05-21 |
주식회사 피테크 |
무통 주사 장치
|
CA3089906A1
(en)
|
2018-02-08 |
2019-08-15 |
Amgen Inc. |
Low ph pharmaceutical antibody formulation
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
US20210363172A1
(en)
|
2018-03-15 |
2021-11-25 |
Biontech Rna Pharmaceuticals Gmbh |
5'-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing rna, expressing proteins in therapy
|
TW202003565A
(zh)
|
2018-03-23 |
2020-01-16 |
美商必治妥美雅史谷比公司 |
抗mica及/或micb抗體及其用途
|
EP3777889A4
(de)
|
2018-03-26 |
2022-01-26 |
Shanghai Yile Biotechnology Co., Ltd. |
Verwendung von probdnf-regulator in b-zell-verwandten krankheiten
|
US11155618B2
(en)
|
2018-04-02 |
2021-10-26 |
Bristol-Myers Squibb Company |
Anti-TREM-1 antibodies and uses thereof
|
WO2019194858A1
(en)
|
2018-04-03 |
2019-10-10 |
Achaogen, Inc. |
Modular synthesis of aminoglycosides
|
AU2019249255A1
(en)
|
2018-04-06 |
2020-11-05 |
Alastair GARFIELD |
Compositions for treating kidney disease
|
CA3096674A1
(en)
|
2018-04-12 |
2019-10-17 |
Bristol-Myers Squibb Company |
Anticancer combination therapy with cd73 antagonist antibody and pd-1/pd-l1 axis antagonist antibody
|
KR20210011919A
(ko)
|
2018-04-17 |
2021-02-02 |
셀덱스 쎄라퓨틱스, 인크. |
항-cd27 항체 및 항-pd-l1 항체 및 이중특이적 작제물
|
WO2019202160A2
(en)
|
2018-04-20 |
2019-10-24 |
Iomx Therapeutics Ag |
A 5-thiazolecarboxamide kinase inhibitor and uses thereof
|
KR102104080B1
(ko)
*
|
2018-05-02 |
2020-04-23 |
주식회사 피테크 |
무통 주사기용 음파발진장치 및 이를 구비하는 무통 주사기
|
KR102107578B1
(ko)
*
|
2018-05-02 |
2020-05-07 |
주식회사 피테크 |
무통 주사기용 약액주입 제어장치 및 이를 구비하는 무통 주사기
|
KR101907552B1
(ko)
*
|
2018-05-03 |
2018-10-12 |
주식회사 피테크 |
무바늘 무통 주사 장치
|
CA3096703A1
(en)
|
2018-05-03 |
2019-11-07 |
University Of Rochester |
Anti-influenza neuraminidase monoclonal antibodies and uses thereof
|
CA3101364A1
(en)
|
2018-05-25 |
2019-11-28 |
Primmune Therapeutics, Inc. |
Tlr7 agonists
|
EP3800999A4
(de)
|
2018-06-04 |
2022-06-01 |
Biogen MA Inc. |
Anti-vla-4-antikörper mit reduzierter effektorfunktion
|
US11951286B2
(en)
*
|
2018-06-12 |
2024-04-09 |
Banza Stamping Industry Corp. |
Automatic injection device for fluid
|
GB201809746D0
(en)
|
2018-06-14 |
2018-08-01 |
Berlin Chemie Ag |
Pharmaceutical combinations
|
EA202190092A1
(ru)
|
2018-06-21 |
2021-05-18 |
Юманити Терапьютикс, Инк. |
Композиции и способы лечения и профилактики неврологических расстройств
|
CA3103431A1
(en)
|
2018-06-27 |
2020-01-02 |
Bioxcel Therapeutics, Inc. |
Film formulations containing dexmedetomidine and methods of producing them
|
MX2021000263A
(es)
|
2018-07-11 |
2021-05-12 |
Kahr Medical Ltd |
Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma.
|
US11929160B2
(en)
|
2018-07-16 |
2024-03-12 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and compliance detection
|
JP2021532140A
(ja)
|
2018-07-30 |
2021-11-25 |
アムジェン リサーチ (ミュニック) ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cd33及びcd3に結合する二重特異性抗体コンストラクトの長期投与
|
MA53333A
(fr)
|
2018-07-31 |
2021-11-03 |
Amgen Inc |
Formulations pharmaceutiques d'anticorps masqués
|
EP3830122A1
(de)
|
2018-07-31 |
2021-06-09 |
Amgen Research (Munich) GmbH |
Dosierungsschema für bispezifische bcma-cd3-antikörper
|
MA53330A
(fr)
|
2018-08-03 |
2021-06-09 |
Amgen Inc |
Constructions d'anticorps pour cldn18.2 et cd3
|
JP7193058B2
(ja)
|
2018-08-08 |
2022-12-20 |
イミューンオンコ バイオファーマシューティカルズ (シャンハイ) インコーポレイテッド |
Cd47およびher2を標的とする組換え二機能性タンパク質
|
WO2020049208A1
(es)
|
2018-09-09 |
2020-03-12 |
Fundacio Privada Institut De Recerca De La Sida - Caixa |
Aurora cinasa como diana para tratar, prevenir o curar una infección por vih o sida
|
WO2020061210A1
(en)
|
2018-09-18 |
2020-03-26 |
Merrimack Pharmaceuticals, Inc. |
Anti-tnfr2 antibodies and uses thereof
|
CA3113436A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
KR102199724B1
(ko)
*
|
2018-10-05 |
2021-01-07 |
주식회사 피테크 |
무바늘 무통 주사 장치
|
JP2022504839A
(ja)
|
2018-10-10 |
2022-01-13 |
ティロス・セラピューティクス・インコーポレイテッド |
抗lap抗体変異体及びその使用
|
JP2022512636A
(ja)
|
2018-10-11 |
2022-02-07 |
アムジエン・インコーポレーテツド |
二重特異性抗体コンストラクトの下流プロセシング
|
EP3643713A1
(de)
|
2018-10-23 |
2020-04-29 |
iOmx Therapeutics AG |
Heterocyclische kinasehemmer und verwendungen davon
|
US20220024944A1
(en)
|
2018-10-23 |
2022-01-27 |
Myelopro Diagnostics And Research Gmbh |
Compounds targeting mutant calreticulin
|
US11160791B2
(en)
|
2018-11-01 |
2021-11-02 |
Medefil, Inc. |
Dexmedetomidine injection premix formulation in ready to use (RTU) bags
|
US11827670B2
(en)
|
2018-11-09 |
2023-11-28 |
University Of Massachusetts |
Anti-CfaE antibodies and methods of use
|
PE20211284A1
(es)
|
2018-11-16 |
2021-07-19 |
Bristol Myers Squibb Co |
Anticuerpos anti-nkg2a y usos de los mismos
|
JP2022513653A
(ja)
|
2018-11-28 |
2022-02-09 |
ブリストル-マイヤーズ スクイブ カンパニー |
修飾された重鎖定常領域を含む抗体
|
WO2020118011A1
(en)
|
2018-12-06 |
2020-06-11 |
Alexion Pharmaceuticals, Inc. |
Anti-alk2 antibodies and uses thereof
|
CN113195532A
(zh)
|
2018-12-18 |
2021-07-30 |
瑞泽恩制药公司 |
使用针对瘦素受体、gdf8和活化素a的拮抗剂增加体重和瘦肌肉质量的组合物和方法
|
WO2020128863A1
(en)
|
2018-12-19 |
2020-06-25 |
Novartis Ag |
Anti-tnf-alpha antibodies
|
WO2020132378A2
(en)
|
2018-12-22 |
2020-06-25 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising depression
|
WO2020144535A1
(en)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Methods and compositions for treatment of multiple myeloma
|
CN113924292A
(zh)
|
2019-01-16 |
2022-01-11 |
库扎环球有限责任公司 |
抗微生物化合物和方法
|
CN113825748A
(zh)
|
2019-01-16 |
2021-12-21 |
库扎环球有限责任公司 |
抗微生物化合物和方法
|
CN109762067B
(zh)
|
2019-01-17 |
2020-02-28 |
北京天广实生物技术股份有限公司 |
结合人Claudin 18.2的抗体及其用途
|
CA3127236A1
(en)
|
2019-01-22 |
2020-07-30 |
Bristol-Myers Squibb Company |
Antibodies against il-7r alpha subunit and uses thereof
|
JP7061236B2
(ja)
|
2019-01-22 |
2022-04-27 |
エオビアン ファーマシューティカルズ, インコーポレイテッド |
Mtorcモジュレーターおよびその使用
|
WO2020154405A2
(en)
|
2019-01-22 |
2020-07-30 |
Genentech, Inc. |
Immunoglobulin a antibodies and methods of production and use
|
CA3128215A1
(en)
|
2019-01-31 |
2020-08-06 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
CA3131953A1
(en)
|
2019-03-01 |
2020-09-10 |
Merrimack Pharmaceuticals, Inc. |
Anti-tnfr2 antibodies and uses thereof
|
BR112021017644A2
(pt)
|
2019-03-11 |
2021-11-16 |
Biogen Ma Inc |
Composições farmacêuticas contendo anticorpos anti-lingo-1
|
AU2020248404A1
(en)
|
2019-03-25 |
2021-09-30 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
MX2021012160A
(es)
|
2019-04-08 |
2022-01-06 |
Biogen Ma Inc |
Anticuerpos antiintegrina y usos de los mismos.
|
JP2022533233A
(ja)
|
2019-05-21 |
2022-07-21 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫調整剤
|
CA3140075A1
(en)
|
2019-06-11 |
2020-12-17 |
Regeneron Pharmaceuticals, Inc. |
Anti-pcrv antibodies that bind pcrv, compositions comprising anti-pcrv antibodies, and methods of use thereof
|
TW202045711A
(zh)
|
2019-06-13 |
2020-12-16 |
美商安進公司 |
生物製品製造中基於生物量之自動灌注控制
|
CN114127125A
(zh)
|
2019-07-08 |
2022-03-01 |
安进公司 |
多特异性甲状腺素转运蛋白免疫球蛋白融合物
|
MX2022000367A
(es)
|
2019-07-11 |
2022-07-13 |
Kahr Medical Ltd |
Heterodimeros, metodos y uso de los mismos.
|
EP3999538A1
(de)
|
2019-07-15 |
2022-05-25 |
Intervet International B.V. |
Caninisierte antikörper gegen canines ctla-4
|
EP3999543A1
(de)
|
2019-07-15 |
2022-05-25 |
Bristol-Myers Squibb Company |
Anti-trem-1-antikörper und verwendungen davon
|
WO2021011681A1
(en)
|
2019-07-15 |
2021-01-21 |
Bristol-Myers Squibb Company |
Antibodies against human trem-1 and uses thereof
|
AU2020312687A1
(en)
|
2019-07-15 |
2022-01-27 |
Intervet International B.V. |
Caninized antibodies to human and canine CTLA-4
|
CA3145388A1
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
EP4003296A1
(de)
|
2019-07-31 |
2022-06-01 |
ModernaTX, Inc. |
Zusammensetzungen und verfahren zur abgabe von rna-interferenzmitteln an immunzellen
|
WO2021021729A1
(en)
|
2019-07-31 |
2021-02-04 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
CA3145580A1
(en)
|
2019-08-09 |
2021-02-18 |
Kaleo, Inc. |
Devices and methods for delivery of substances within a prefilled syringe
|
MX2022001866A
(es)
|
2019-08-13 |
2022-03-11 |
Amgen Inc |
Muteinas de interleucina-2 para la expansion de celulas t reguladoras.
|
KR20220079857A
(ko)
|
2019-09-13 |
2022-06-14 |
루트거스, 더 스테이트 유니버시티 오브 뉴 저지 |
Aav-상용성 라미닌-링커 중합 단백질
|
KR20220088868A
(ko)
|
2019-10-30 |
2022-06-28 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제
|
EP3819007A1
(de)
|
2019-11-11 |
2021-05-12 |
Amgen Research (Munich) GmbH |
Dosierschema für anti-bcma-wirkstoffe
|
AU2020384885A1
(en)
|
2019-11-13 |
2022-06-09 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
CA3156683A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
METHOD FOR REDUCING AGGREGATE FORMATION IN DOWNSTREAM PROCESSING OF BI-SPECIFIC ANTIGEN-BINDING MOLECULES
|
WO2021102143A1
(en)
|
2019-11-19 |
2021-05-27 |
Bristol-Myers Squibb Company |
Macrocyclic peptides as pd-l1 inhibitors and immunomodulators for the treatment of cancer and infectious diseases
|
BR112022011350A2
(pt)
|
2019-12-11 |
2022-08-23 |
Visterra Inc |
Composições e métodos para tratamento e prevenção da influenza
|
JP2023507115A
(ja)
|
2019-12-17 |
2023-02-21 |
アムジエン・インコーポレーテツド |
治療における使用のためのデュアルインターロイキン-2/tnf受容体アゴニスト
|
MX2022007636A
(es)
|
2019-12-20 |
2022-07-19 |
Intervet Int Bv |
Anticuerpos biespecificos caninizados y pares de union biespecificos para el tratamiento contra dermatitis atopica.
|
MX2022007672A
(es)
|
2019-12-20 |
2022-07-19 |
Intervet Int Bv |
Anticuerpos del receptor alfa de interleucina-4 canina.
|
UY38995A
(es)
|
2019-12-20 |
2021-06-30 |
Amgen Inc |
Constructos de anticuerpo multiespecíficos agonistas de cd40 dirigidos a mesotelina para el tratamiento de tumores sólidos
|
CN114929714A
(zh)
|
2020-01-06 |
2022-08-19 |
百时美施贵宝公司 |
用于治疗癌症和感染性疾病的作为pd-l1抑制剂和免疫调节剂的大环肽
|
JP2023510737A
(ja)
|
2020-01-06 |
2023-03-15 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫調節剤
|
CN110818795B
(zh)
|
2020-01-10 |
2020-04-24 |
上海复宏汉霖生物技术股份有限公司 |
抗tigit抗体和使用方法
|
WO2021150824A1
(en)
|
2020-01-22 |
2021-07-29 |
Amgen Research (Munich) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
CA3169669A1
(en)
|
2020-01-31 |
2021-08-05 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
US20230105029A1
(en)
|
2020-02-27 |
2023-04-06 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Antibodies binding il4r and uses thereof
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
US20230140384A1
(en)
|
2020-03-09 |
2023-05-04 |
Bristol-Myers Squibb Company |
Antibodies to cd40 with enhanced agonist activity
|
US20230183292A1
(en)
|
2020-03-16 |
2023-06-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
KR20220155338A
(ko)
|
2020-03-19 |
2022-11-22 |
암젠 인크 |
뮤신 17에 대한 항체 및 이의 용도
|
WO2021195089A1
(en)
|
2020-03-23 |
2021-09-30 |
Sorrento Therapeutics, Inc. |
Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, compositions and methods of use thereof
|
KR20220161407A
(ko)
|
2020-03-30 |
2022-12-06 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제
|
CA3170570A1
(en)
|
2020-04-01 |
2021-10-07 |
James J. KOBIE |
Monoclonal antibodies against the hemagglutinin (ha) and neuraminidase (na) of influenza h3n2 viruses
|
US20230272056A1
(en)
|
2020-04-09 |
2023-08-31 |
Merck Sharp & Dohme Llc |
Affinity matured anti-lap antibodies and uses thereof
|
CA3168737A1
(en)
|
2020-04-21 |
2021-10-28 |
Jiaxi WU |
Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof
|
EP3901151A1
(de)
|
2020-04-21 |
2021-10-27 |
iOmx Therapeutics AG |
Halogenierte heteroaryl- und andere heterocyclische kinaseinhibitoren und verwendungen davon
|
US11634477B2
(en)
|
2020-04-28 |
2023-04-25 |
The Rockefeller University |
Neutralizing anti-SARS-CoV-2 antibodies and methods of use thereof
|
WO2021219731A2
(en)
|
2020-04-28 |
2021-11-04 |
Iomx Therapeutics Ag |
Bicyclic kinase inhibitors and uses thereof
|
AU2021263813A1
(en)
|
2020-04-29 |
2022-10-27 |
Amgen Inc. |
Pharmaceutical formulation
|
US20230167176A1
(en)
|
2020-04-29 |
2023-06-01 |
Amgen Inc. |
Pharmaceutical formulation
|
BR112022022045A2
(pt)
|
2020-04-30 |
2023-01-10 |
Sairopa B V |
Anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao cd103 humano, um ou mais ácidos nucleicos, sistema de expressão, célula hospedeira, composição, métodos de produção de um anticorpo ou fragmento de ligação ao antígeno, para detectar a presença de cd103 em uma amostra biológica, para tratar ou prevenir uma condição mediada por sinalização de cd103 em um indivíduo em necessidade, para inibir a sinalização de cd103 em uma célula, para inibir a ligação de cd103 à e-caderina presente em uma célula, para retirar as células que expressam cd103 em um indivíduo, para tratar ou prevenir uma doença e agente de imageamento
|
CN115916340A
(zh)
|
2020-05-08 |
2023-04-04 |
百时美施贵宝公司 |
免疫调节剂
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
WO2021231732A1
(en)
|
2020-05-15 |
2021-11-18 |
Bristol-Myers Squibb Company |
Antibodies to garp
|
MX2022014636A
(es)
|
2020-05-19 |
2023-02-23 |
Amgen Inc |
Construcciones de unión a mageb2.
|
US20230277524A1
(en)
|
2020-05-22 |
2023-09-07 |
Trailhead Biosystems Inc. |
Combination therapy for treatment of viral infections
|
JP2023527972A
(ja)
|
2020-05-29 |
2023-07-03 |
アムジエン・インコーポレーテツド |
Cd33及びcd3に結合する二重特異性コンストラクトの有害作用軽減投与
|
WO2021252708A1
(en)
|
2020-06-11 |
2021-12-16 |
President And Fellows Of Harvard College |
Stabilized trioxacarcin antibody drug conjugates and uses thereof
|
FR3112939B1
(fr)
|
2020-07-31 |
2024-01-05 |
Univ Montpellier |
Produit universel de thérapie cellulaire et son utilisation
|
EP4192511A1
(de)
|
2020-08-07 |
2023-06-14 |
Fortis Therapeutics, Inc. |
Gegen cd46 gerichtete immunkonjugate und verfahren zur verwendung davon
|
KR20230058432A
(ko)
|
2020-08-24 |
2023-05-03 |
암젠 인크 |
약제학적 제형
|
US20230365627A1
(en)
|
2020-10-02 |
2023-11-16 |
Bristol-Myers Squibb Company |
Macrocyclic peptide boronate immunomodulators
|
JP2023546020A
(ja)
|
2020-10-08 |
2023-11-01 |
ブリストル-マイヤーズ スクイブ カンパニー |
新規二量体免疫調節剤
|
CN116323640A
(zh)
|
2020-10-09 |
2023-06-23 |
百时美施贵宝公司 |
大环免疫调节剂
|
MX2023004438A
(es)
|
2020-10-15 |
2023-05-08 |
Intervet Int Bv |
Anticuerpos de rata caninizados para el receptor alfa de interleucina-31 canino.
|
WO2022092294A1
(ja)
|
2020-10-30 |
2022-05-05 |
学校法人慶應義塾 |
サルコペニア関連疾患等の新規治療および予防
|
JPWO2022092295A1
(de)
|
2020-10-30 |
2022-05-05 |
|
|
AR123997A1
(es)
|
2020-11-04 |
2023-02-01 |
Univ Rockefeller |
ANTICUERPOS NEUTRALIZANTES CONTRA EL SARS-CoV-2
|
WO2022096704A1
(en)
|
2020-11-06 |
2022-05-12 |
Amgen Inc. |
Antigen binding domain with reduced clipping rate
|
BR112023008670A2
(pt)
|
2020-11-06 |
2024-02-06 |
Amgen Inc |
Construtos polipeptídicos ligados à cd3
|
JP2023547662A
(ja)
|
2020-11-06 |
2023-11-13 |
アムジェン リサーチ (ミュニック) ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cldn6及びcd3に選択的に結合するポリペプチド構築物
|
AU2021374839A1
(en)
|
2020-11-06 |
2023-06-08 |
Amgen Inc. |
Multitargeting bispecific antigen-binding molecules of increased selectivity
|
TW202233682A
(zh)
|
2020-11-10 |
2022-09-01 |
美商安進公司 |
用於投與BCMAxCD3結合分子之方法
|
CN116547305A
(zh)
|
2020-11-11 |
2023-08-04 |
生物技术公司 |
针对程序性死亡-1蛋白的单克隆抗体及其在医学中的用途
|
AR124267A1
(es)
|
2020-12-09 |
2023-03-01 |
Genentech Inc |
Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos
|
CN114685669A
(zh)
|
2020-12-30 |
2022-07-01 |
和铂医药(苏州)有限公司 |
结合trop2的抗体及其用途
|
US20220227844A1
(en)
|
2021-01-15 |
2022-07-21 |
The Rockefeller University |
Neutralizing anti-sars-cov-2 antibodies
|
EP4305088A1
(de)
|
2021-03-09 |
2024-01-17 |
Massachusetts Institute of Technology |
Verzweigte poly(aminoester) zur verabreichung von nukleinsäuren
|
JP2024510207A
(ja)
|
2021-03-12 |
2024-03-06 |
ブリストル-マイヤーズ スクイブ カンパニー |
Kras阻害剤
|
WO2022204412A1
(en)
|
2021-03-24 |
2022-09-29 |
Bristol-Myers Squibb Company |
Immunomodulators
|
BR112023020303A2
(pt)
|
2021-04-09 |
2023-11-14 |
Celldex Therapeutics Inc |
Anticorpos contra ilt4, anticorpo anti-ilt4/pd-l1 bispecífico e seus usos
|
KR20230169230A
(ko)
|
2021-04-12 |
2023-12-15 |
브리스톨-마이어스 스큅 컴퍼니 |
시클릭 펩티드 면역조정제
|
EP4333805A1
(de)
|
2021-05-06 |
2024-03-13 |
Amgen Inc. |
Etelcalcetidformulierungen
|
EP4334358A1
(de)
|
2021-05-06 |
2024-03-13 |
Amgen Research (Munich) GmbH |
Cd20 und cd22 zielende antigenbindende moleküle zur verwendung bei proliferativen erkrankungen
|
WO2022235867A2
(en)
|
2021-05-06 |
2022-11-10 |
The Rockefeller University |
Neutralizing anti-sars- cov-2 antibodies and methods of use thereof
|
KR20240017813A
(ko)
|
2021-05-10 |
2024-02-08 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
신경질환 치료용 약학적 조성물
|
IL308545A
(en)
|
2021-05-26 |
2024-01-01 |
Oxford Biotherapeutics Ltd |
A medical preparation that includes an anti-CD205 antibody and an immune checkpoint inhibitor
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
EP4352077A1
(de)
|
2021-06-09 |
2024-04-17 |
Bristol-Myers Squibb Company |
Zyklische peptidimmunmodulatoren
|
WO2022258792A1
(en)
|
2021-06-09 |
2022-12-15 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel anti-fibrotic drugs
|
CA3220933A1
(en)
|
2021-06-30 |
2023-01-05 |
Amgen Inc. |
Method of reconstituting lyophilized formulation
|
WO2023288213A1
(en)
|
2021-07-12 |
2023-01-19 |
Bristol-Myers Squibb Company |
Macrocyclic immunomodulators
|
KR20240035843A
(ko)
|
2021-07-19 |
2024-03-18 |
브리스톨-마이어스 스큅 컴퍼니 |
마크로시클릭 면역조정제
|
IL309799A
(en)
|
2021-07-20 |
2024-02-01 |
Regeneron Pharma |
Butyrophilin-2-like substances for the treatment of inflammatory disorders
|
CN113398365B
(zh)
*
|
2021-07-21 |
2022-10-28 |
南京瑞淇卓越医疗美容诊所有限公司 |
一种心血管内科用的临床造影注射装置及注射方法
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
AU2022329459A1
(en)
|
2021-08-20 |
2024-02-29 |
Intervet International B.V. |
Antibodies and igg fusion proteins with an extended half-life
|
AU2022331810A1
(en)
|
2021-08-20 |
2024-02-29 |
Intervet International B.V. |
Fusion proteins for treating atopic dermatitis
|
WO2023039108A1
(en)
|
2021-09-08 |
2023-03-16 |
Affinivax, Inc. |
Coronavirus vaccine
|
CN113773401B
(zh)
|
2021-09-15 |
2023-06-20 |
宜明昂科生物医药技术(上海)股份有限公司 |
靶向cd47和pd-l1的重组融合蛋白及其制备和用途
|
CA3233926A1
(en)
|
2021-10-08 |
2023-04-13 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
CN113754769B
(zh)
|
2021-10-13 |
2023-06-06 |
宜明昂科生物医药技术(上海)股份有限公司 |
靶向cd70的抗体及其制备和用途
|
CN113831412B
(zh)
|
2021-10-13 |
2023-06-20 |
宜明昂科生物医药技术(上海)股份有限公司 |
靶向cd24的抗体及其制备和用途
|
CN113956363B
(zh)
|
2021-10-13 |
2023-03-31 |
宜明昂科生物医药技术(上海)股份有限公司 |
靶向cd47和cd24的重组融合蛋白及其制备和用途
|
WO2023069994A1
(en)
|
2021-10-20 |
2023-04-27 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CA3233696A1
(en)
|
2021-11-03 |
2023-05-11 |
Joachim Koch |
Bispecific cd16a binders
|
WO2023079493A1
(en)
|
2021-11-03 |
2023-05-11 |
Affimed Gmbh |
Bispecific cd16a binders
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
WO2023077521A1
(en)
|
2021-11-08 |
2023-05-11 |
Celldex Therapeutics, Inc |
Anti-ilt4 and anti-pd-1 bispecific constructs
|
WO2023089314A1
(en)
|
2021-11-18 |
2023-05-25 |
Oxford Biotherapeutics Limited |
Pharmaceutical combinations
|
WO2023096904A2
(en)
|
2021-11-24 |
2023-06-01 |
President And Fellows Of Harvard College |
C-16 modified trioxacarcins, antibody drug conjugates, and uses thereof
|
WO2023102507A1
(en)
|
2021-12-03 |
2023-06-08 |
Bristol-Myers Squibb Company |
Macrocyclic immunomodulators
|
WO2023105281A1
(en)
|
2021-12-11 |
2023-06-15 |
Fundaciò Privada Institut De Recerca De La Sida-Caixa |
Soluble tigit recombinant proteins
|
WO2023114884A2
(en)
|
2021-12-15 |
2023-06-22 |
Interius Biotherapeutics, Inc. |
Pseudotyped viral particles, compositions comprising the same, and uses thereof
|
WO2023111157A1
(en)
|
2021-12-16 |
2023-06-22 |
Intervet International B.V. |
Caninized and felinized antibodies to human ngf
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
WO2023111148A1
(en)
|
2021-12-16 |
2023-06-22 |
Intervet International B.V. |
Caninized antibodies to canine interleukin-31 receptor alpha 1
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023147399A1
(en)
|
2022-01-27 |
2023-08-03 |
The Rockefeller University |
Broadly neutralizing anti-sars-cov-2 antibodies targeting the n-terminal domain of the spike protein and methods of use thereof
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023166488A1
(en)
|
2022-03-04 |
2023-09-07 |
Revagenix, Inc. |
Broad spectrum aminoglycosides and uses thereof
|
WO2023177579A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023175171A1
(en)
|
2022-03-18 |
2023-09-21 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Bk polyomavirus antibodies and uses thereof
|
WO2023192873A1
(en)
|
2022-03-28 |
2023-10-05 |
Bristol-Myers Squibb Company |
Macrocyclic immunomodulators
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
EP4257132A1
(de)
|
2022-04-08 |
2023-10-11 |
iOmx Therapeutics AG |
Sik3-inhibitoren zum behandeln von krankheiten, die gegen death-rezeptor -signaltransduktion resistent sind
|
EP4257609A1
(de)
|
2022-04-08 |
2023-10-11 |
iOmx Therapeutics AG |
Kombinationstherapien basierend auf pd-1-inhibitoren und sik3-inhibitoren
|
WO2023212559A1
(en)
|
2022-04-26 |
2023-11-02 |
Amgen Inc. |
Lyophilization method
|
US11932693B2
(en)
|
2022-05-12 |
2024-03-19 |
BioNTech SE |
Monoclonal antibodies directed against programmed death-1 protein and their use in medicine
|
WO2023218027A1
(en)
|
2022-05-12 |
2023-11-16 |
Amgen Research (Munich) Gmbh |
Multichain multitargeting bispecific antigen-binding molecules of increased selectivity
|
GB202207263D0
(en)
|
2022-05-18 |
2022-06-29 |
Annexin Pharmaceuticals Ab |
Therapeutic compositions
|
WO2023225661A1
(en)
|
2022-05-20 |
2023-11-23 |
Bristol-Myers Squibb Company |
Macrocyclic immunomodulators
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023240188A1
(en)
|
2022-06-10 |
2023-12-14 |
Bristol-Myers Squibb Company |
Pyrido[4,3-d]pyrimidine derivatives as kras inhibitors
|
WO2023240189A1
(en)
|
2022-06-10 |
2023-12-14 |
Bristol-Myers Squibb Company |
Tetrahydropyrido 3,4-d pyrimidine derivatives as kras inhibitors
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024036270A1
(en)
|
2022-08-11 |
2024-02-15 |
Bristol-Myers Squibb Company |
Kras inhibitors
|
WO2024040109A2
(en)
|
2022-08-16 |
2024-02-22 |
Bristol-Myers Squibb Company |
Kras inhibitors
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
WO2024054926A1
(en)
|
2022-09-07 |
2024-03-14 |
Bristol-Myers Squibb Company |
Kras g12d inhibitors
|
WO2024059472A1
(en)
|
2022-09-12 |
2024-03-21 |
Bristol-Myers Squibb Company |
Macrocyclic immunomodulators
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|